Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
     
(Mark One)    
þ
  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the quarterly period ended September 30, 2005
 
OR
 
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    Commission file number: 1-32381
 
HERBALIFE LTD.
(Exact name of registrant as specified in its charter)
     
Cayman Islands
  98-0377871
(State or other jurisdiction
of incorporation or organization)
  (I.R.S. Employer
Identification No.)
P.O. Box 309GT
Ugland House, South Church Street
Grand Cayman, Cayman Islands
(Address of principal executive offices) (Zip code)
(310) 410-9600*
(Registrant’s telephone number, including area code)
     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes þ          No o
      Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).     Yes o          No þ
      Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes o          No þ
      Number of shares of registrant’s common shares outstanding as of November 1, 2005 was 69,400,666.
 
C/ O Chief Financial Officer of Herbalife International, Inc.
 
 


HERBALIFE LTD.
INDEX TO FINANCIAL STATEMENTS AND EXHIBITS
Filed with the Quarterly Report of the Company on Form 10-Q
For the Three and Nine Months Ended September 30, 2005
             
 PART I. FINANCIAL INFORMATION
   Financial Statements:     2  
     Unaudited Consolidated Balance Sheets     2  
     Unaudited Consolidated Statements of Income     3  
     Unaudited Consolidated Statements of Cash Flows     4  
     Notes to Unaudited Consolidated Financial Statements     5  
   Management’s Discussion and Analysis of Financial Condition and Results of Operations     15  
   Quantitative and Qualitative Disclosures About Market Risk     32  
   Controls and Procedures     34  
 Forward Looking Statements     34  
 PART II. OTHER INFORMATION
   Legal Proceedings     36  
   Unregistered Sales of Equity Securities and Use of Proceeds     36  
   Defaults Upon Senior Securities     36  
   Submission of Matters to a Vote of Security Holders     36  
   Other Information     36  
   Exhibits     36  
 Signatures and Certifications     41  
 EX-31.1
 EX-31.2
 EX-32.1

1


Table of Contents

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
HERBALIFE LTD.
CONSOLIDATED BALANCE SHEETS
                   
    December 31,   September 30,
    2004   2005
         
        (Unaudited)
ASSETS
CURRENT ASSETS:
               
 
Cash and cash equivalents
  $ 201,577,000     $ 105,180,000  
 
Receivables, net of allowance for doubtful accounts of $4,815,000 (2004) and $5,113,000 (2005)
    29,546,000       40,787,000  
 
Inventories
    71,092,000       86,376,000  
 
Prepaid expenses and other current assets
    45,914,000       33,574,000  
 
Deferred income taxes
    21,784,000       14,705,000  
             
Total current assets
    369,913,000       280,622,000  
 
Property, at cost, net of accumulated depreciation and amortization of $20,463,000 (2004) and $25,473,000 (2005)
    55,390,000       62,108,000  
 
Deferred compensation plan assets
    12,052,000       13,079,000  
 
Other assets
    7,957,000       7,000,000  
 
Deferred financing costs, net of accumulated amortization of $231,000 (2004) and $926,000 (2005)
    6,860,000       4,281,000  
 
Marketing franchise
    310,000,000       310,000,000  
 
Distributor network, net of accumulated amortization of $45,272,000 (2004) and $56,200,000 (2005)
    10,928,000        
 
Product certification, product formulae and other intangible assets, net of accumulated amortization of $14,692,000 (2004) and $17,017,000 (2005)
    8,084,000       5,759,000  
 
Goodwill
    167,517,000       144,553,000  
             
TOTAL
  $ 948,701,000     $ 827,402,000  
             
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
               
 
Accounts payable
  $ 24,457,000     $ 27,640,000  
 
Royalty overrides
    85,304,000       81,239,000  
 
Accrued compensation
    27,016,000       34,745,000  
 
Accrued expenses
    87,227,000       88,754,000  
 
Current portion of long term debt
    120,291,000       7,004,000  
 
Advance sales deposits
    9,490,000       18,023,000  
 
Income taxes payable
    17,684,000       13,819,000  
             
Total current liabilities
    371,469,000       271,224,000  
NON-CURRENT LIABILITIES:
               
 
Long term debt, net of current portion
    365,926,000       281,324,000  
 
Deferred compensation
    13,882,000       14,347,000  
 
Deferred income taxes
    130,346,000       127,357,000  
 
Other non-current liabilities
    2,736,000       2,334,000  
             
Total liabilities
    884,359,000       696,586,000  
             
COMMITMENTS AND CONTINGENCIES
               
SHAREHOLDERS’ EQUITY:
               
 
Common shares, $0.002 par value, 175,000,000 shares authorized, 68,630,834 (2004) and 69,347,198 (2005) shares issued and outstanding
    137,000       139,000  
 
Paid-in-capital in excess of par value
    74,593,000       78,836,000  
 
Accumulated other comprehensive income
    3,923,000       2,965,000  
 
Retained earnings (accumulated deficit)
    (14,311,000 )     48,876,000  
             
Total shareholders’ equity
    64,342,000       130,816,000  
             
TOTAL
  $ 948,701,000     $ 827,402,000  
             
See the accompanying notes to consolidated financial statements

2


Table of Contents

HERBALIFE LTD.
CONSOLIDATED STATEMENTS OF INCOME
                                   
    Three Months Ended   Nine Months Ended
         
    September 30,   September 30,   September 30,   September 30,
    2004   2005   2004   2005
                 
    (Unaudited)
Product sales
  $ 274,671,000     $ 345,761,000     $ 831,329,000     $ 997,384,000  
Handling & freight income
    45,138,000       55,236,000       136,692,000       160,340,000  
                         
Net sales
    319,809,000       400,997,000       968,021,000       1,157,724,000  
Cost of sales
    68,961,000       79,482,000       198,824,000       232,592,000  
                         
Gross profit
    250,848,000       321,515,000       769,197,000       925,132,000  
Royalty overrides
    111,978,000       138,618,000       342,366,000       410,875,000  
Selling, general & administrative expenses
    102,772,000       121,584,000       315,811,000       349,430,000  
                         
Operating income
    36,098,000       61,313,000       111,020,000       164,827,000  
Interest expense, net
    13,604,000       7,950,000       55,233,000       37,598,000  
                         
Income before income taxes
    22,494,000       53,363,000       55,787,000       127,229,000  
Income taxes
    11,004,000       26,226,000       32,693,000       64,042,000  
                         
NET INCOME
  $ 11,490,000     $ 27,137,000     $ 23,094,000     $ 63,187,000  
                         
Earnings per share:
                               
 
Basic
  $ 0.22     $ 0.39     $ 0.44     $ 0.92  
 
Diluted
  $ 0.21     $ 0.37     $ 0.42     $ 0.87  
Weighted average shares outstanding:
                               
 
Basic
    52,265,000       69,077,000       52,121,000       68,800,000  
 
Diluted
    55,660,000       73,455,000       55,246,000       72,373,000  
See the accompanying notes to consolidated financial statements

3


Table of Contents

HERBALIFE LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS
                     
    Nine Months Ended
     
    September 30,   September 30,
    2004   2005
         
    (Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
               
Net income
    23,094,000       63,187,000  
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
   
Depreciation and amortization
    34,287,000       27,749,000  
   
Amortization of discount and deferred financing costs
    5,213,000       1,098,000  
   
Deferred income taxes
    491,000       6,397,000  
   
Unrealized foreign exchange loss
    389,000       (2,303,000 )
   
Write-off of deferred financing costs and unamortized discounts
    4,077,000       5,388,000  
   
Other
    1,743,000       3,078,000  
 
Changes in operating assets and liabilities:
               
   
Receivables
    (1,355,000 )     (11,185,000 )
   
Inventories
    (18,991,000 )     (17,703,000 )
   
Prepaid expenses and other current assets
    (8,087,000 )     11,102,000  
   
Accounts payable
    (1,052,000 )     4,638,000  
   
Royalty overrides
    286,000       (957,000 )
   
Accrued expenses and accrued compensation
    30,068,000       12,281,000  
   
Advance sales deposits
    6,894,000       8,578,000  
   
Income taxes payable
    12,660,000       19,066,000  
   
Deferred compensation liability
    (8,736,000 )     464,000  
             
NET CASH PROVIDED BY OPERATING ACTIVITIES
    80,981,000       130,878,000  
             
CASH FLOWS FROM INVESTING ACTIVITIES:
               
   
Purchases of property
    (16,810,000 )     (21,761,000 )
   
Proceeds from sale of property
    27,000       33,000  
   
Net change in restricted cash
    5,701,000        
   
Changes in other assets
    (3,723,000 )     7,000  
   
Deferred compensation plan assets
    1,776,000       (1,027,000 )
             
NET CASH USED IN INVESTING ACTIVITIES
    (13,029,000 )     (22,748,000 )
             
CASH FLOWS FROM FINANCING ACTIVITIES:
               
   
Dividends paid on Preferred Shares
    (38,500,000 )      
   
Issuance of 91/2% Notes
    267,437,000        
   
Borrowings from long-term debt
    1,709,000       172,000  
   
Principal payments on long-term debt
    (59,072,000 )     (201,700,000 )
   
Conversion of Preferred Shares
    (183,115,000 )      
   
Repurchase of 151/2% Senior Notes
    (39,644,000 )      
   
Exercise of Stock Options
    761,000       1,599,000  
   
Other
          (374,000 )
             
NET CASH USED IN FINANCING ACTIVITIES
    (50,424,000 )     (200,303,000 )
             
EFFECT OF EXCHANGE RATE CHANGES ON CASH
    (3,538,000 )     (4,224,000 )
             
NET CHANGE IN CASH AND CASH EQUIVALENTS
    13,990,000       (96,397,000 )
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
    150,679,000       201,577,000  
             
CASH AND CASH EQUIVALENTS, END OF PERIOD
    164,669,000       105,180,000  
             
CASH PAID FOR:
               
Interest
    38,646,000       28,003,000  
             
Income taxes
    20,930,000       35,846,000  
             
NON-CASH ACTIVITIES:
               
Acquisitions of property through capital leases
    3,871,000       540,000  
             
See the accompanying notes to consolidated financial statements

4


Table of Contents

HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Organization
      Herbalife Ltd., a Cayman Islands exempted limited liability company (“Herbalife”), incorporated on April 4, 2002, and its direct and indirect wholly-owned subsidiaries, WH Intermediate Holdings Ltd., a Cayman Islands company (“WH Intermediate”), WH Luxembourg Holdings S.à.R.L., a Luxembourg unipersonal limited liability company (“Lux Holdings”), WH Luxembourg CM S.à.R.L., a Luxembourg unipersonal limited liability company, and WH Acquisition Corp., a Nevada corporation (“WH Acquisition”), were formed on behalf of Whitney & Co., LLC (“Whitney”) and Golden Gate Private Equity, Inc. (“Golden Gate”), in order to acquire Herbalife International, Inc., a Nevada corporation, and its subsidiaries (“Herbalife International”) on July 31, 2002 (the “Acquisition”). Herbalife and its subsidiaries are referred to collectively herein as the Company.
IPO Recapitalization
      On December 16, 2004, Herbalife completed an initial public offering (the “IPO”), whereby it offered its common shares as part of a series of recapitalization transactions as follows:
  •  a tender offer for $159.8 million of the outstanding 113/4% senior subordinated notes due 2010, issued by Herbalife International, which are referred to as the 113/4% Notes;
 
  •  the replacement of Herbalife International’s existing $205.0 million senior credit facility with a new $225.0 million senior credit facility;
 
  •  the payment of a $139.8 million special cash dividend to the then current shareholders of Herbalife, in which the new purchasers of Herbalife common shares in the IPO were not entitled to participate; and
 
  •  the amendment of Herbalife’s Memorandum and Articles of Association to: (1) effect a 1:2 reverse stock split of Herbalife’s common shares; (2) increase Herbalife’s authorized common shares to 500 million shares; and (3) increase Herbalife’s authorized preference shares to 7.5 million shares, all of which took effect on December 1, 2004.
      As a planned continuation of the IPO recapitalization, Herbalife exercised a contract provision in December 2004 to redeem 40%, or $110.0 million principal value (excluding a premium of $10.5 million), of the 91/2% notes due 2011, which are referred to as the 91/2% Notes. After the required notice period, this redemption was completed on February 4, 2005. The redemption premium of $10.5 million and the write-off of deferred financing fees of $3.7 million associated with this redemption are included in interest expense in the first quarter of 2005.
      In connection with the IPO and the recapitalization, the Company incurred $24.5 million in fees and expenses of which $19.7 million were associated with the IPO (included in equity) and $4.8 million were associated with the establishment of the new credit facility (included in deferred financing costs).
2. Basis of Presentation
      The unaudited interim financial information of the Company has been prepared in accordance with Article 10 of the Securities and Exchange Commission’s Regulation S-X. Accordingly, it does not include all of the information required by generally accepted accounting principles for complete financial statements. The Company’s financial statements as of and for the three and nine months ended September 30, 2005 include Herbalife and all of its direct and indirect subsidiaries. In the opinion of management, the accompanying financial information contains all adjustments, consisting of normal recurring adjustments, necessary to present fairly the Company’s financial statements as of September 30, 2005 and for the three and nine months ended September 30, 2004 and September 30, 2005. Operating results for the three and nine months ended September 30, 2005 are not necessarily indicative of the results that may be expected for the year ending December 31, 2005.

5


Table of Contents

HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
New Accounting Pronouncements
      In December 2004, the Financial Accounting Standards Board (“FASB”) enacted Statement of Financial Accounting Standards 123 — revised 2004 (“SFAS 123R”), “Share-Based Payment” which replaces Statement of Financial Accounting Standards No. 123 (“SFAS 123”), “Accounting for Stock-Based Compensation” and supersedes Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees.” SFAS 123R requires the measurement of all employee share-based payments to employees, including grants of employee stock options, using a fair-value-based method and the recording of such expense in our consolidated statements of income. The accounting provisions of SFAS 123R are effective for reporting periods beginning after December 15, 2005.
      The Company is required to adopt SFAS 123R in the first quarter of fiscal 2006. The pro forma disclosures previously permitted under SFAS 123 no longer will be an alternative to financial statement recognition. See Note 8 in the Notes to Consolidated Financial Statements for the pro forma net income and net income per share amounts, for the three and nine months ended September 30, 2004 and September 30, 2005, as if the Company had used a fair-value-based method similar to the methods required under SFAS 123R to measure compensation expense for employee stock incentive awards. Although the Company has not yet determined whether the adoption of SFAS 123R will result in amounts that are similar to the current pro forma disclosures under SFAS 123, the Company is evaluating the requirements under SFAS 123R and on a preliminary basis management expects the adoption will not have a material impact on the Company’s consolidated statements of income.
      In December 2004, the FASB issued FASB Staff Position No. FAS 109-2 (“FAS 109-2”), “Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creations Act of 2004” (“AJCA”). The AJCA introduces a limited time 85% dividends received deduction on the repatriation of certain foreign earnings to a U.S. taxpayer (“repatriation provision”), provided certain criteria are met. FAS 109-2 provides accounting and disclosure guidance for the repatriation provision. This provision will not provide a material benefit to the Company.
      In December 2004, the FASB issued SFAS No. 151, “Inventory Costs, an amendment of ARB No. 43, Chapter 4,” which requires that abnormal amounts of idle facility expense, freight, handling costs and wasted material (spoilage) be recognized as current-period charges. In addition, the statement requires that allocation of fixed production overheads to the costs of conversion be based on the normal capacity of the production facilities. SFAS No. 151 is effective for fiscal years beginning after June 15, 2005. The Company will adopt this statement as required, and management does not believe the adoption will have a material effect on the Company’s results of operations, financial condition or liquidity.
      In May 2005, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 154, “Accounting Changes and Error Corrections.” SFAS No. 154 requires restatement of prior periods’ financial statements for changes in accounting principle, unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. Also, SFAS No. 154 requires that retrospective application of a change in accounting principle be limited to the direct effects of the change. SFAS No. 154 is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005.
Reclassifications
      Certain reclassifications were made to the prior period financial statements to conform to current period presentation.
3. Transactions with related parties
      The Company entered into agreements with Whitney and Golden Gate to pay monitoring fees for their services and other fees and expenses. Under the monitoring fee agreements, the Company was obligated to pay

6


Table of Contents

HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
an annual amount of up to $5.0 million, but not less than $2.5 million for an initial period of ten years subject to the provisions in Herbalife International’s credit agreement. On December 1, 2004, the Company agreed with Whitney and Golden Gate to terminate the monitoring fee agreements in consideration for 0.7 million warrants, which were valued at approximately $2.9 million using the Black-Scholes option pricing model and the entire impact of which was included in Selling, General & Administrative expenses in 2004. For the three and nine months ended September 30, 2004, the Company expensed monitoring fees in the amount of $1.3 million and $3.8 million, and other expenses of $0.3 million and $1.4 million, respectively.
      In December 2004, the Company entered into a termination agreement with the parties to the Share Purchase Agreement. Pursuant to the termination agreement, the Share Purchase Agreement and all obligations and liabilities of the parties under the Share Purchase Agreement were terminated. As consideration for the termination of the Share Purchase Agreement, the Company entered into a Tax Indemnification Agreement with Whitney and Golden Gate (and/or their affiliates) pursuant to which the Company has agreed to indemnify each of those parties for the Federal income tax liability and any related losses they incur in respect of income of Herbalife that is (or would be) includible in the gross income of that party for any taxable period under Section 951(a) of the Internal Revenue Code of 1986, as amended (the “Code”). Under the terms of the Tax Indemnification Agreement, the Company assumes, for this purpose, that each indemnified party is a “United States shareholder” as defined in Section 951(b) of the Code. The Company does not, however, have any obligation to provide an indemnity with respect to any taxes or related losses incurred that have been reimbursed under the Share Purchase Agreement. The Company’s credit facility permits the Company to pay these tax indemnity payments, but restricts the aggregate amount that the Company can pay in any given year to no more than $15 million. The Company currently anticipates that any amounts that are required to be paid under this agreement in the future will be immaterial to the Company’s financial condition and operating results.
      In 2004, Whitney acquired a 50 percent indirect ownership interest in Shuster Laboratories, Inc. (“Shuster”), a provider of product testing and formula development for Herbalife. For the three and nine months ended September 30, 2005, total purchases from Shuster were zero and $0.02 million, respectively. For the three and nine months ended September 30, 2004, there were no purchases from Shuster.
      In 2004, Whitney acquired a 50 percent indirect ownership interest in TBA Entertainment (“TBA”), a provider of creative services to Herbalife. While there were no services performed in 2004 by TBA for Herbalife, for the three and nine months ended September 30, 2005 payments of $0.02 million and $5.71 million, respectively, were made to TBA for services relating to the 25th Anniversary Extravaganza, the majority of which were reimbursements of Extravaganza expenses paid to third parties.
      In 2004, Golden Gate acquired a 47 percent ownership interest in Leiner Health Products Inc. (“Leiner”), a nutritional manufacturer and supplier of certain Herbalife products. For the three and nine months ended September 30, 2005, total purchases from Leiner were zero and $0.14 million, respectively. For the three and nine months ended September 30, 2004, total purchases from Leiner were zero and $0.35 million, respectively.
      In January 2005, Whitney, together with its affiliates, acquired a 77 percent ownership interest in Stauber Performance Ingredients (“Stauber”), a value-added distributor of bulk specialty nutraceutical ingredients. For the three and nine months ended September 30, 2005, total purchases from Stauber were $0.40 million and $0.85 million, respectively.
      The Company believes that the transactions with the above entities were done on an “arms length” basis with “fair market pricing”.

7


Table of Contents

HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
4. Long-Term Debt
                 
    As of
     
    December 31,   September 30,
    2004   2005
         
    (Dollars in millions)
Borrowings under senior credit facility
  $ 200.0     $ 119.1  
91/2% Notes
    268.1       161.2  
113/4% Notes
    0.2       0.1  
Capital leases
    9.2       5.3  
Other debt
    8.7       2.6  
             
      486.2       288.3  
Less: current portion
    120.3       7.0  
             
    $ 365.9     $ 281.3  
             
      In February 2005, the Company redeemed $110.0 million principal value or 40% of the outstanding principal amount of the 91/2% Notes for a cash payment of $124.1 million, which included a redemption premium of $10.5 million and accrued interest of $3.6 million. In addition, the Company expensed $3.7 million of related unamortized deferred financing costs and discount.
      In the second and third quarters of 2005, the Company made prepayments to the term loan borrowings under the senior credit facility of $35.0 million and $44.7 million, respectively. Consequently, the Company expensed $0.7 million and $0.9 million of related unamortized deferred financing costs in the second and third quarters of 2005, respectively.
5. Contingencies
      The Company is from time to time engaged in routine litigation. The Company regularly reviews all pending litigation matters in which it is involved and establishes reserves deemed appropriate by management for these litigation matters when a probable loss estimate can be made.
      Herbalife International and certain of its distributors have been named as defendants in a purported class action lawsuit filed July 16, 2003 in the Circuit Court of Ohio County in the State of West Virginia (Mey v. Herbalife International, Inc., et al). The complaint alleges that certain telemarketing practices of certain Herbalife International distributors violate the Telephone Consumer Protection Act, or TCPA, and seeks to hold Herbalife International vicariously liable for the practices of its distributors. More specifically, the plaintiffs’ complaint alleges that several of Herbalife International’s distributors used pre-recorded telephone messages and autodialers to contact prospective customers in violation of the TCPA’s prohibition of such practices. Herbalife International’s distributors are independent contractors and, if any such distributors in fact violated the TCPA, they also violated Herbalife’s policies, which require its distributors to comply with all applicable federal, state and local laws. The Company believes that it has meritorious defenses to the suit.
      Herbalife International and certain of its independent distributors have been named as defendants in a purported class action lawsuit filed February 17, 2005 in the Superior Court of California, County of San Francisco, and served on Herbalife International on March 14, 2005 (Minton v. Herbalife International, et al). The case has been transferred to the Los Angeles County Superior Court. The plaintiff is challenging the marketing practices of certain Herbalife International independent distributors and Herbalife International under various state laws prohibiting “endless chain schemes,” insufficient disclosure in assisted marketing plans, unfair and deceptive business practices, and fraud and deceit. The plaintiff alleges that the Freedom Group system operated by certain independent distributors of Herbalife International products places too much emphasis on recruiting and encourages excessively large purchases of product and promotional materials

8


Table of Contents

HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
by distributors. The plaintiff also alleges that Freedom Group pressured distributors to disseminate misleading promotional materials. The plaintiff seeks to hold Herbalife International vicariously liable for the actions of its independent distributors and is seeking damages and injunctive relief. The Company believes that it has meritorious defenses to the suit.
      In February 2005, Herbalife voluntarily elected to temporarily withdraw its Sesame & Herb tablet product from the Israeli market. This product, which has been on the market since 1989, is sold only in Israel. Herbalife’s voluntary decision to temporarily withdraw this product accompanied the initiation of a review by the Israeli Ministry of Health (the “Israel MOH”) of a small number of anecdotal case reports of individuals having liver dysfunction who had also consumed Herbalife products. Herbalife scientists and medical doctors are closely cooperating with the Israel MOH to facilitate this ongoing review. In May 2005, the Israel MOH issued a press release stating that although their investigation was continuing, no causal link has been shown between the consumption of Herbalife products and liver function abnormalities. In addition, the Israel MOH requested that individuals consuming or intending to consume Herbalife products obtain liver function tests before and one month after beginning their use, and that persons with liver function disorders refrain from consuming dietary supplements. Independent analysis of Herbalife’s Israeli products has confirmed that Herbalife products do not contain any substances indicated by the Israel MOH as being of concern in relation to this small number of reported cases of liver dysfunction. The Company believes that Herbalife products are not the cause of these few reported anecdotal cases of liver dysfunction.
      As a marketer of dietary and nutritional supplements and other products that are ingested by consumers or applied to their bodies, the Company has been and is currently subjected to various product liability claims. The effects of these claims to date have not been material to us, and the reasonably possible range of exposure on currently existing claims is not material to the Company. The Company believes that it has meritorious defenses to the allegations contained in the lawsuits. The Company currently maintains product liability insurance with a self insured retention of $10 million.
      Certain of the Company’s subsidiaries have been subject to tax audits by governmental authorities in their respective countries. In certain of these tax audits, governmental authorities are proposing that significant amounts of additional taxes and related interest and penalties are due. The Company and its tax advisors believe that there are substantial defenses to the allegations that additional taxes are owing, and the Company is vigorously contesting the additional proposed taxes and related charges.
      These matters may take several years to resolve, and the Company cannot be sure of their ultimate resolution. However, it is the opinion of management that adverse outcomes, if any, will not likely result in a material effect on the Company’s financial condition and operating results. This opinion is based on the belief that any losses suffered in excess of amounts reserved would not be material and that the Company has meritorious defenses. Although the Company has reserved an amount that it believes represents the likely outcome of the resolution of these disputes, if the Company is incorrect in the assessment, the Company may have to record additional expenses.

9


Table of Contents

HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
6. Comprehensive Income
                                 
    Three Months Ended   Nine Months Ended
         
    September 30,   September 30,   September 30,   September 30,
    2004   2005   2004   2005
                 
Net income
  $ 11.5     $ 27.1     $ 23.1     $ 63.2  
Unrealized gain on derivative instruments
          0.4       3.2       0.3  
Reclassification adjustments for loss on derivative instruments
                (1.8 )      
Foreign currency translation adjustment
    0.5       (0.6 )     (1.7 )     (1.9 )
                         
Comprehensive income
  $ 12.0     $ 26.9     $ 22.8     $ 61.6  
                         
7. Segment Information
      The Company is a network marketing company that sells a wide range of weight management products, nutritional supplements and personal care products within one industry segment as defined under SFAS 131, “Disclosures about Segments of an Enterprise and Related Information.” The Company’s products are manufactured by third party providers and then sold to independent distributors who sell Herbalife products to retail consumers or other distributors.
      The Company sells products in 60 countries throughout the world and is organized and managed by geographic region. In the first quarter of 2003, the Company elected to aggregate its operating segments into one reporting segment, as management believes that the Company’s operating segments have similar operating characteristics and similar long term operating performance. In making this determination, management believes that the operating segments are similar with regard to the nature of the products sold, the product acquisition process, the types of customers products are sold to, the methods used to distribute the products, and the nature of the regulatory environment.
      Revenues reflect sales of products to distributors based on the distributors’ geographic location. Sales attributed to the United States is the same as reported in the geographic operating information.

10


Table of Contents

HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      The Company’s geographic operating information and sales by product line are as follows:
                                   
    Three Months Ended   Nine Months Ended
         
    September 30,   September 30,   September 30,   September 30,
    2004   2005   2004   2005
                 
Net Sales:
                               
United States
  $ 61.4     $ 70.7     $ 194.9     $ 215.9  
Japan
    22.4       24.1       73.9       71.2  
Mexico
    26.5       61.5       70.3       149.0  
Others
    209.5       244.7       628.9       721.6  
                         
 
Total Net Sales
  $ 319.8     $ 401.0     $ 968.0     $ 1,157.7  
                         
Operating margin:
                               
United States
  $ 25.8     $ 32.9     $ 81.1     $ 92.2  
Japan
    12.3       12.0       38.9       36.0  
Mexico
    10.6       27.4       28.4       64.8  
Others
    90.2       110.6       278.4       321.2  
                         
 
Total Operating margin
  $ 138.9     $ 182.9     $ 426.8     $ 514.2  
                         
Selling, general and administrative expense
    102.8       121.6       315.8       349.4  
Interest expense, net
    13.6       8.0       55.2       37.6  
                         
Income before income taxes and minority interest
    22.5       53.3       55.8       127.2  
Income taxes
    11.0       26.2       32.7       64.0  
                         
Net Income
  $ 11.5     $ 27.1     $ 23.1     $ 63.2  
                         
Net sales by product line:
                               
Weight management
  $ 137.4     $ 176.9     $ 419.5     $ 502.0  
Inner nutrition
    138.5       167.1       415.9       476.6  
Outer Nutrition®
    28.3       37.0       86.0       123.0  
Literature, promotional and other
    15.6       20.0       46.6       56.1  
                         
 
Total Net Sales
  $ 319.8     $ 401.0     $ 968.0     $ 1,157.7  
                         
Net sales by geographic region:
                               
Americas
  $ 116.1     $ 180.7     $ 343.5     $ 488.1  
Europe
    127.5       131.2       401.6       417.6  
Asia/ Pacific Rim (excluding Japan)
    53.8       65.0       149.0       180.8  
Japan
    22.4       24.1       73.9       71.2  
                         
 
Total Net Sales
  $ 319.8     $ 401.0     $ 968.0     $ 1,157.7  
                         

11


Table of Contents

HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
                   
    As of
     
    December 31,   September 30,
    2004   2005
         
    (In millions)
Total Assets:
               
United States
  $ 587.8     $ 448.0  
Japan
    60.3       55.2  
Mexico
    27.5       42.2  
Others
    273.1       282.0  
             
 
Total Assets
  $ 948.7     $ 827.4  
             
8. Stock Based Compensation
      The Company has five stock based compensation plans which are the WH Holdings (Cayman Islands) Ltd. Stock Incentive Plan (“The Management Plan”), the WH Holdings (Cayman Islands) Ltd. Independent Directors Stock Incentive Plan (“The Independent Directors Plan”), the Herbalife Ltd. 2004 Incentive Plan (“2004 Stock Incentive Plan”), the 2005 Stock Incentive Plan (the “2005 Stock Incentive Plan”) and the Herbalife Ltd. Executive Incentive Plan (the “Executive Incentive Plan”). The Management Plan provides for the grant of options to purchase common shares of Herbalife to members of the Company’s management. The Independent Directors Plan provides for the grant of options to purchase common shares of Herbalife to the Company’s independent directors. The 2004 Stock Incentive Plan is intended to replace the Management Plan and the Independent Directors Plan. No additional awards will be made under either the Management Plan or the Independent Directors Plan. However, the shares remaining available for issuance under these plans will be absorbed by and become available for issuance under the 2004 Stock Incentive Plan. The 2005 Stock Incentive Plan authorizes the issuance of 4,000,000 common shares pursuant to awards, plus any shares that remain available for issuance under the 2004 Stock incentive Plan. The terms of the 2005 Stock Incentive Plan are substantially similar to the terms of the 2004 Stock Incentive Plan. The purpose of the Executive Incentive Plan is to govern the award and payment of annual bonuses to certain company executives.
      The Company applies the intrinsic-value-based method of accounting prescribed by Accounting Principles Board (“APB”) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations including the Financial Accounting Standards Board (“FASB”) Interpretation No. 44, Accounting for Certain Transactions involving Stock Compensation, an interpretation of APB Opinion No. 25, issued in March 2000, to account for its stock option plans. Under this method, compensation expense is recorded on the date of grant to the extent the then current market price of the underlying stock exceeds the exercise price. SFAS 123, Accounting for Stock Based Compensation, established accounting and disclosure requirements using a fair-value-based method of accounting for stock based employee compensation plans. As allowed by SFAS 123, the Company has elected to continue to apply the intrinsic-value-based method of accounting described above, and has adopted only the disclosure requirements of SFAS 123.

12


Table of Contents

HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      The following table illustrates the effect on net income if the fair-value-based method had been applied to all outstanding and vested awards in each period:
                                   
    Three Months Ended   Nine Months Ended
         
    September 30,   September 30,   September 30,   September 30,
    2004   2005   2004   2005
                 
    (In millions)
Net income as reported
  $ 11.5     $ 27.1       23.1     $ 63.2  
Add: Stock-based employee compensation expense included in reported net income, net of tax
    0.3       0.2       0.9       1.5  
less: Stock-based employee compensation expense determined under fair value based methods for all awards, net of tax
    (0.2 )     (1.4 )     (1.1 )     (5.3 )
                         
Pro forma net income
  $ 11.6     $ 25.9     $ 22.9     $ 59.4  
                         
Basic earnings per share
                               
 
As reported
  $ 0.22     $ 0.39     $ 0.44     $ 0.92  
 
Pro forma
  $ 0.22     $ 0.38     $ 0.44     $ 0.86  
Diluted earnings per share
                               
 
As reported
  $ 0.21     $ 0.37     $ 0.42     $ 0.87  
 
Pro forma
  $ 0.21     $ 0.35     $ 0.41     $ 0.82  
9. Derivative Instruments and Hedging Activities
      The Company designates certain derivatives as cash flow hedges. The Company engages in a foreign exchange hedging strategy for which the hedged transactions are forecasted foreign currency denominated intercompany transactions. The hedged risk is the variability of the forecasted foreign currency cash flows where the hedging strategy involves the purchase of average rate options. The Company also engages in an interest rate hedging strategy for which the hedged transactions are forecasted interest payments on the Company’s variable rate term loan. The hedged risk is the variability of forecasted interest rate cash flows, where the hedging strategy involves the purchase of interest rate swaps. For the outstanding cash flow hedges on foreign exchange exposures at September 30, 2004 and September 30, 2005, the maximum length of time over which the Company is hedging these exposures is 3 months. For the outstanding cash flow hedges on interest rate exposures at September 30, 2004 and September 30, 2005, the maximum length of time over which the Company is hedging these exposures is approximately three years. For all qualifying and highly effective cash flow hedges, the changes in the effective portion of the fair value of the derivative are deferred and recorded in other comprehensive income (“OCI”) until the related forecasted transaction is recognized in the consolidated statements of income. The estimated net amount of existing gains and losses expected to be reclassified into earnings over the next 12 months is $0.5 million. The ineffective portion of the hedges was $0.07 million for the nine months ended September 30, 2005. At September 30, 2005, the pre-tax OCI balance related to the cash flow hedges was $1.1 million ($0.6 million post-tax).
      The Company designates certain derivatives as free standing derivatives for which hedge accounting does not apply. The changes in the fair market value of the derivatives are recorded in the Company’s statements of income. The Company purchases average rate put options, which give the Company the right, but not the obligation, to sell foreign currency at a specified exchange rate (“strike rate”). These contracts provide protection in the event the foreign currency weakens beyond the option strike rate. The Company also uses foreign currency forward contracts, which give the Company the obligation to buy or sell foreign currency at a specified time and rate. The contracts are used to protect against changes in the functional currency equivalent

13


Table of Contents

HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
value of inter-company or third party nonfunctional currency payables and receivables. The fair values of the option and forward contracts are based on third-party bank quotes.
10. Restructuring Reserve
      As of the date of the Acquisition, the Company began to assess and formulate a plan to reduce costs of the business and recorded a severance and restructuring accrual as part of the cost of the Acquisition. The accrued severance is for employees including executives, corporate functions, and administrative support that were identified at the time of the Acquisition. Actions required by the plan of termination began immediately after consummation of the transaction.
      The following table summarizes the activity in the Company’s restructuring accrual:
                 
    January 1, 2004 to   January 1, 2005 to
    December 31,   September 30,
    2004   2005
         
    (In millions)
Beginning balance
  $ 2.5     $ 0.7  
Reduction of accrual
          (0.4 )
Payments made
    (1.8 )     (0.3 )
             
Ending Balance
  $ 0.7     $ 0.0  
             

14


Table of Contents

Item 2. Management’s Discussion And Analysis Of Financial Condition And Results Of Operations
Overview
      We are a global network marketing company that sells weight management, nutritional supplement and personal care products. We pursue our mission of “changing people’s lives” by providing a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle. We are one of the largest network marketing companies in the world with net sales of approximately $1.3 billion for the year ended December 31, 2004. We sell our products in 60 countries through a network of over one million independent distributors. We believe the quality of our products and the effectiveness of our distribution network, coupled with geographic expansion, have been the primary reasons for our success throughout our 25-year operating history.
      We offer products in three principal categories: weight management products, nutritional supplements which we refer to as “inner nutrition” and personal care products which we refer to as “Outer Nutrition®”. Our products are often sold in programs, which are comprised of a series of related products designed to simplify weight management and nutrition for our consumers and maximize our distributors’ cross-selling opportunities.
      Industry-wide factors that affect us and our competitors include the increasing prevalence of obesity and the aging of the worldwide population, which are driving demand for nutrition and wellness-related products and the recruitment and retention of distributors.
      The opportunities and challenges upon which we are most focused are driving retailing of our product, recruitment and retention of distributors and improving distributor productivity, entering new markets, including China, further penetrating existing markets, pursuing local distributor initiatives, introducing new products, developing niche market segments and further investing in our infrastructure.
      A key non-financial measure we focus on is Volume Points on a Royalty Basis (hereafter “Volume Points”), which is essentially our weighted unit measure of product sales volume. It is a useful measure for us, as it excludes the impact of foreign currency fluctuations and ignores the differences generated by varying retail pricing across geographic markets. In general, an increase in Volume Points in a particular region or country directionally indicates an increase in local currency net sales.
Volume Points by Geographic Region
                                                 
    Three Months Ended   Nine Months Ended
         
    September 30,   September 30,       September 30,   September 30,    
    2004   2005   % Change   2004   2005   % Change
                         
    (volume points in millions)
The Americas
    192.6       281.4       46.1 %     556.3       771.5       38.7 %
Europe
    133.5       140.6       5.3 %     437.3       432.8       (1.0 )%
Asia/ Pacific Rim
    73.3       83.6       14.0 %     196.2       225.6       15.0 %
Japan
    16.5       18.3       10.9 %     55.0       52.5       (4.5 )%
                                     
Worldwide
    415.9       523.9       26.0 %     1,244.8       1,482.4       19.1 %
                                     
      Another key non-financial measure on which we focus on is the number of distributors qualified as supervisors under our compensation system. Distributors qualify for supervisor status based on their Volume Points.
      The growth in the number of supervisors is a general indicator of the level of distributor recruitment, which generally drives net sales in a particular country or region. Our compensation system requires each supervisor to qualify for such status each year, prior to February. There is significant variation in the number of supervisors from the fourth quarter to the first quarter of any given year due to the qualification process that occurs during this period. This fluctuation is normal and consistent, does not reflect a dramatic underlying change in the business in comparing these two sequential quarters, and will become more meaningful period to period throughout the year.

15


Table of Contents

      The following tables show trends in the number of supervisors over the reporting period by region. Fluctuations within each notable country are discussed in the appropriate net sales section below where pertinent.
Number of Supervisors by Geographic Region as of Reporting Period
                         
    As of September 30,
     
    2004   2005   % Change
             
The Americas
    108,024       136,536       26.4 %
Europe
    94,064       86,364       (8.2 )%
Asia/ Pacific Rim
    48,308       54,804       13.4 %
Japan
    16,056       12,327       (23.2 )%
                   
Worldwide
    266,452       290,031       8.8 %
                   
Number of Supervisors by Geographic Region as of Requalification Period
                         
    As of February,
     
    2004   2005   % Change
             
The Americas
    75,359       87,925       16.7 %
Europe
    70,239       65,104       (7.3 )%
Asia/ Pacific Rim
    31,790       38,524       21.2 %
Japan
    13,946       9,547       (31.5 )%
                   
Worldwide
    191,334       201,100       5.1 %
                   
      Supervisors must requalify annually. The requalification period covers the twelve months starting in February and ending the following January. The number of supervisors by geographic region as of the reporting dates will normally be higher than the number of supervisors by geographic region as of the requalification period because supervisors who do not requalify during the relevant twelve-month period will be dropped from the rank of supervisor in February. Since supervisors purchase most of our products for resale to other distributors and consumers, comparisons of supervisor totals on a year-to-year, same period basis are good indicators of our recruitment and retention efforts in different geographic regions.
      The value of the average monthly purchase of Herbalife products by our supervisors has remained relatively constant over time. Consequently, increases in our sales are driven primarily by our retention of supervisors and by our recruitment and retention of distributors, rather than through increases in the productivity of our overall supervisor base.
      In 2004 we made a modification to the supervisor requalification criteria as a limited test. This modification allowed distributors who otherwise would have failed to requalify as supervisors to continue to purchase products from the Company and to receive the benefit of product discounts, while forfeiting their down-line royalties. We believe this test was successful because we retained approximately 10,000 distributors, and generated approximately 12 million additional Volume Points, annualized, which would represent approximately $9.4 million in net sales, $5.2 million in operating margin and an immaterial impact to Selling, General & Administrative Expenses. As a result of the test, the Company has modified the supervisor requalification criteria for all distributors in 2005.
      We provide distributors with products, support material, training, special events and a competitive compensation program. If a distributor wants to pursue the Herbalife business opportunity, the distributor is responsible for growing his or her business and personally pays for the sales activities related to attracting new customers and recruiting distributors by hosting events such as Herbalife Opportunity Meetings or Success Training Seminars; by advertising Herbalife’s products; by purchasing and using promotional materials such as t-shirts, buttons and caps; by utilizing and paying for direct mail and print material such as brochures, flyers, catalogs, business cards, posters and banners and telephone book listings; by purchasing inventory for sale or

16


Table of Contents

use as samples; and by training, mentoring and following up (in person or via the phone or internet) with customers and recruits on how to use Herbalife products and/or pursue the Herbalife business opportunity.
Presentation
      “Retail Sales” represent the gross sales amounts on our invoices to distributors before distributor allowances (as defined below), and “net sales”, which reflects distribution allowances and handling and freight income, is what the Company collects and recognizes as net sales in its financial statements. We discuss Retail Sales because of its fundamental role in our compensation systems, internal controls and operations, including its role as the basis upon which distributor discounts, royalties and bonuses are awarded. In addition, information in daily and monthly reports reviewed by our management relies on Retail Sales data. However, such a measure is not in accordance with Generally Accepted Accounting Principles in the U.S. (“GAAP”). You should not consider Retail Sales in isolation from, nor as a substitute for, net sales and other consolidated income or cash flow statement data prepared in accordance with GAAP, or as a measure of profitability or liquidity. A reconciliation of net sales to Retail Sales is presented below under “Results of Operations.” “Product sales” represent the actual product purchase price paid to us by our distributors, after giving effect to distributor discounts referred to as “distributor allowances,” which approximate 50% of retail sales prices. Distributor allowances as a percentage of sales may vary by country depending upon regulatory restrictions that limit or otherwise restrict distributor allowances.
      Our “gross profit” consists of net sales less “cost of sales,” which represents the prices we pay to our raw material suppliers and manufacturers of our products as well as costs related to product shipments, duties and tariffs, freight expenses relating to shipment of products to distributors and importers and similar expenses.
      “Royalty Overrides” are our most significant expense and consist of:
  •  royalty overrides, or commissions, and bonuses, which total approximately 15% and 7%, respectively, of the Retail Sales of weight management, inner nutrition, Outer Nutrition® and promotional products;
 
  •  the Mark Hughes Bonus payable to some of our most senior distributors in the aggregate amount of approximately 1% of Retail Sales of weight management, inner nutrition, Outer Nutrition® and promotional products; and
 
  •  other discretionary incentive cash bonuses to qualifying distributors.
      Royalty Overrides are generally earned based on Retail Sales, and approximate in the aggregate about 23% of Retail Sales or approximately 35% of our net sales. Royalty Overrides together with distributor allowances represent the potential earnings to distributors of up to approximately 73% of Retail Sales. The compensation to distributors is generally for the development, retention and improved productivity of their distributor sales organizations and is paid to several levels of distributors on each sale. Because of local country regulatory constraints, we may be required to modify our typical distributor incentive plans as described above. Consequently, the total distributor discount percentage may vary over time. We also offer reduced distributor allowances and pay reduced royalty overrides with respect to certain products worldwide. Non-U.S. royalty checks that have aged, for a variety of reasons, beyond a certainty of being paid, are taken back into income. Management has calculated this period of certainty to be three years worldwide, whereas previously this period varied by country, ranging from 12 months to 30 years. In order to achieve consistency among all countries, the Company adjusted the period over which such amounts would be taken into income to three years on a Company-wide basis beginning with the third quarter of 2004.
      Our “operating margins” consist of net sales less cost of sales and royalty overrides.
      “Selling, General and Administrative Expenses” represent our operating expenses, components of which include labor and benefits, sales events, professional fees, travel and entertainment, distributor marketing, occupancy costs, communication costs, bank fees, depreciation and amortization, foreign exchange gains and losses and other miscellaneous operating expenses.
      “113/4% Notes” refers to Herbalife International’s 113/4% senior subordinated notes due 2010. “91/2% Notes” refers to our 91/2% notes due 2011.

17


Table of Contents

      Most of our sales to distributors outside the United States are made in the respective local currencies. In preparing our financial statements, we translate revenues into U.S. dollars using average exchange rates. Additionally, the majority of our purchases from our suppliers generally are made in U.S. dollars. Consequently, a strengthening of the U.S. dollar versus a foreign currency can have a negative impact on our reported sales and operating margins and can generate transaction losses on intercompany transactions. Throughout the last five years, foreign currency exchange rates have fluctuated significantly. From time to time, we enter into foreign exchange forward contracts and option contracts to mitigate our foreign currency exchange risk.
Summary Financial Results
      For the three and nine months ended September 30, 2005, net sales increased by 25.4% and 19.6%, respectively, as compared to the same periods in 2004. The combination of continued strong recruitment and retention of distributors and retailing of our products in our key markets, various promotions leading up to the 25th Anniversary Extravaganza in Atlanta in April 2005 and the Worldwide Cup promotions during 2005, generally favorable foreign currency exchange rates, the launch of new products such as Liftoff tm and Nourifusiontm coupled with the ongoing roll out of ShapeWorkstm and NiteWorkstm to more countries, contributed to the sales increase. For the three months ended September 30, 2005, net sales increased in all regions for the first time in seven years. Also, after six years of sales declines in Japan, sales increased in the third quarter of 2005 as compared to the third quarter of 2004. The sales growth in the U.S. and South Korea was an encouraging result of our effort and commitment to turn around these countries. Continued strong sales growth in Mexico was primarily attributable to the growth in Nutrition Clubs a party planning concept. For the nine months ended September 30, 2005, net sales increased in all regions except for Japan.
      For the three months ended September 30, 2005, net income was $27.1 million, or 37 cents per diluted share compared to net income of $11.5 million, or 21 cents per diluted share in the same period of 2004. Net income as reported includes a favorable post-tax impact of $2.5 million relating to a change in the allowance for uncollectible royalty overrides receivables from distributors in the third quarter of 2005, partially offset by the $1.5 million favorable post-tax impact of aged royalties in the third quarter of 2004. The improvement in net income was a result of a 25.4% increase in net sales, the continued favorable impact from appreciation of foreign currencies and lower interest expense partially offset by higher operating expenses primarily from increased labor, benefits, incentive compensation and promotion expense. Overall, the appreciation of foreign currencies had a $3.5 million favorable impact on net income for the three months ended September 30, 2005.
      For the nine months ended September 30, 2005, net income was $63.2 million, or 87 cents per diluted share compared to net income of $23.1 million, or 42 cents per diluted share reported for the same period in 2004. Net income as reported includes the effect of recapitalization transaction expenses of $14.2 million and $15.4 million in the first quarters of 2005 and 2004, respectively, a non-cash tax charge of $5.5 million associated with moving our China subsidiary within the global corporate structure in the second quarter of 2005, and the favorable post-tax impact of $2.5 million relating to a change in the allowance for uncollectible royalty overrides receivables from distributors in the third quarter of 2005, partially offset by the $1.5 million favorable post-tax impact of aged royalties in the third quarter of 2004. The improvement in net income was a result of a 19.6% increase in net sales, the continued favorable impact from appreciation of foreign currencies, lower interest and income tax expense partially offset by higher operating expenses primarily from increased labor, benefits, incentive compensation and promotion expense. Overall, the appreciation of foreign currencies had a $10.6 million favorable impact on net income for the nine months ended September 30, 2005.
Results of Operations
      Our results of operations for the periods described below are not necessarily indicative of results of operations for future periods, which depend upon numerous factors, including our ability to recruit and retain new distributors, open new markets and further penetrate existing markets and introduce new products and develop niche market segments.

18


Table of Contents

      The following table sets forth selected results of our operations expressed as a percentage of net sales for the periods indicated.
                                 
    Three Months Ended   Nine Months Ended
         
    September 30,   September 30,   September 30,   September 30,
    2004   2005   2004   2005
                 
Operations:
                               
Net sales
    100.0 %     100.0 %     100.0 %     100.0 %
Cost of sales
    21.6 %     19.8 %     20.5 %     20.1 %
                         
Gross profit
    78.4 %     80.2 %     79.5 %     79.9 %
Royalty overrides
    35.0 %     34.6 %     35.4 %     35.5 %
Selling, general & admin expenses
    32.1 %     30.3 %     32.6 %     30.2 %
                         
Operating income
    11.3 %     15.3 %     11.5 %     14.2 %
Interest expense
    (4.3 )%     (2.0 )%     (5.7 )%     (3.2 )%
                         
Income before income taxes and minority interest
    7.0 %     13.3 %     5.8 %     11.0 %
Income taxes
    3.4 %     6.5 %     3.4 %     5.5 %
                         
Net income
    3.6 %     6.8 %     2.4 %     5.5 %
                         
Net Sales
      The following chart reconciles Retail Sales to net sales:
Sales by Geographic Region
                                                                                         
    Three Months Ended September 30,
     
    2004   2005
         
        Handling &           Handling &       Change
    Retail   Distributor   Product   Freight   Net   Retail   Distributor   Product   Freight   Net   in Net
    Sales   Allowance   Sales   Income   Sales   Sales   Allowance   Sales   Income   Sales   Sales
                                             
    (Dollars in millions)
The Americas
  $ 190.2     $ (91.5 )   $ 98.7     $ 17.4     $ 116.1     $ 297.7     $ (143.1 )   $ 154.6     $ 26.1     $ 180.7       55.6 %
Europe
    207.9       (99.1 )     108.8       18.7       127.5       214.1       (101.7 )     112.4       18.8       131.2       2.9 %
Asia/ Pacific Rim
    87.8       (40.4 )     47.4       6.4       53.8       106.6       (49.1 )     57.5       7.5       65.0       20.8 %
Japan
    38.6       (18.8 )     19.8       2.6       22.4       41.2       (20.0 )     21.2       2.9       24.1       7.6 %
                                                                   
Total
  $ 524.5     $ (249.8 )   $ 274.7     $ 45.1     $ 319.8     $ 659.6     $ (313.9 )   $ 345.7     $ 55.3     $ 401.0       25.4 %
                                                                   
                                                                                         
    Nine Months Ended September 30,
     
    2004   2005
         
        Handling &           Handling &       Change
    Retail   Distributor   Product   Freight   Net   Retail   Distributor   Product   Freight   Net   in Net
    Sales   Allowance   Sales   Income   Sales   Sales   Allowance   Sales   Income   Sales   Sales
                                             
    (Dollars in millions)
The Americas
  $ 557.9     $ (266.0 )   $ 291.9     $ 51.6     $ 343.5     $ 803.8     $ (386.3 )   $ 417.5     $ 70.6     $ 488.1       42.1 %
Europe
    655.8       (313.0 )     342.8       58.8       401.6       682.0       (324.8 )     357.2       60.4       417.6       4.0 %
Asia/ Pacific Rim
    243.7       (112.1 )     131.6       17.4       149.0       296.7       (136.9 )     159.8       21.0       180.8       21.3 %
Japan
    126.6       (61.6 )     65.0       8.9       73.9       122.1       (59.3 )     62.8       8.4       71.2       (3.7 )%
                                                                   
Total
  $ 1,584.0     $ (752.7 )   $ 831.3     $ 136.7     $ 968.0     $ 1,904.6     $ (907.3 )   $ 997.3     $ 160.4     $ 1,157.7       19.6 %
                                                                   
      Changes in net sales are directly associated with the recruiting and retention of our distributor force, retailing of our products, the quality and completeness of the product offerings that the distributor force has to sell and the number of countries in which we operate. Management’s role, both in-country and at the corporate level is to provide distributors with a competitive and broad product line, encourage strong teamwork and leadership among the Chairman’s Club and President’s Team distributors and offer leading edge business

19


Table of Contents

tools to make doing business with Herbalife simple. Management uses the distributor marketing program coupled with educational and motivational tools to incent distributors to drive recruiting, retention and retailing which in turn affect net sales. Such tools include corporate sales events — Extravaganzas and World Team Schools — where large groups of distributors gather, thus allowing them to network with other distributors, learn recruiting, retention and retailing techniques from our leading distributors, and become more familiar with how to market and sell our products and business opportunities. Accordingly, management believes that these development and motivation programs can increase the productivity of the supervisor network. The expenses for such programs are included in Selling, General & Administrative expenses. Sales are driven by several factors including the number and productivity of distributor supverisors who continually build, educate and motivate their respective distribution and sales organizations. We also use event and non-event product promotions to motivate distributors to increase recruiting, retention and retailing activities. These promotions have prizes ranging from qualifying for events to vacations and qualification parties for distributors that meet certain selling and recruiting goals. The costs of these promotions are included in Selling, General & Administrative expenses.
      The factors described above have driven growth in our business. The following net sales by geographic region discussion further details some of the above factors and describes unique growth factors specific to certain major countries. The Company believes that the correct business foundation, coupled with ongoing training and promotional initiatives is required to increase recruiting and retention of distributors and retailing of the product. The correct business foundation includes strong country management that works closely with the distributor leadership, unified distributor leadership, a broad product line that appeals to local consumer needs, a favorable regulatory environment, a scalable and stable technology platform and an attractive distributor marketing plan. Initiatives such as Success Training Seminars, World Team Schools, Promotional Events and regional Extravaganzas are integral components of developing a highly motivated and educated distributor sales organization that will work toward increasing the recruitment and retention of distributors.
      The Company’s strategy will continue to include creating and maintaining growth within existing markets. We expect to increase our spending in Selling, General & Administrative expenses to maintain or stimulate sales growth, while making strategic investments in new initiatives. In addition, new ideas are being generated in our regional markets, either by distributors, country management or corporate management. Examples are the Nutrition Clubs in Mexico, the Total Plan in Brazil and GenH in the U.S., as described in the net sales discussion below. Management’s strategy is to review the applicability of expanding successful country initiatives throughout a region and/or globally and where appropriate, financially support the globalization of these initiatives.
The Americas
      Net sales in The Americas increased $64.6 million and $144.6 million, or 55.6% and 42.1%, respectively, for the three and nine months ended September 30, 2005, as compared to the same periods in 2004. In local currency, net sales increased by 46.3% and 36.6%, respectively, for the three and nine months ended September 30, 2005, as compared to the same periods in 2004. The fluctuation of foreign currency rates had a positive impact on net sales of $10.8 million and $19.0 million, respectively, for the three and nine months ended September 30, 2005. The overall increase was a result of net sales growth in Mexico, Brazil, and the U.S. of $35.0 million, $12.0 million, $9.3 million for the three months ended September 30, 2005, and $78.7 million, $30.4 million, $21.0 million, for the nine months ended September 30, 2005, respectively, compared to the same periods in 2004.
      The net sales growth in Mexico is a result of the continued success of the Nutrition Clubs, strong country management, and highly engaged distributor leadership. The costs to set up a Nutrition Club are generally nominal, and are borne solely by the distributor. We believe our distributors currently operate over 15,000 Nutrition Clubs in Mexico, which have led to an increased number of supervisors, up 69.7% at September 30, 2005 compared to September 30, 2004.
      The net sales growth in Brazil is a result of the continued success of the Total Plan, strong country distributor leadership, a highly effective country management team and a solid product portfolio. The Total

20


Table of Contents

Plan is a low-cost lead generating method where distributors use our personal care line of products and offer consultations to obtain referrals and has led to an increased number of supervisors, up 37.0% at September 30, 2005 compared to September 30, 2004. This concept specifically supports our retailing and recruiting initiatives and has been a catalyst for growth in Brazil. Additionally, the ShapeWorkstm program was introduced at the Brazilian World Team School in July 2005.
      As a result of the numerous steps taken in 2004 and 2005 to improve the business in the U.S., including the establishment of a U.S. country management team, branding efforts such as sponsorship of the JP Morgan Chase tennis tournament, the AVP Volleyball Tour and the Nautica Malibu Triathlon; and various promotions such as the 2005 President’s Team Challenge, the World Team Bonus, the Atlanta Challenge in connection with the 25th Anniversary Extravaganza and the Worldwide Cup promotion, net sales have exceeded the corresponding quarterly results of 2004. At the 25th Anniversary Extravaganza two new products were introduced, Liftoff tm and NouriFusiontm. The number of supervisors increased by 3.2% at September 30, 2005 compared to September 30, 2004, after approximately two consecutive years of year-over-year declines.
      We expect 2005 net sales in the Americas region to continue its growth primarily as a result of the expected continuation of the solid performance in Mexico, Brazil and the U.S.
Europe
      Net sales in Europe increased $3.7 million and $16.0 million, or 2.9%, and 4.0%, respectively, for the three and nine months ended September 30, 2005, as compared to the same periods in 2004. In local currency, net sales increased by 2.3% and 0.9%, respectively, for the three and nine months ended September 30, 2005, as compared to the same periods in 2004. The fluctuation of foreign currency rates had a positive impact on net sales of $0.6 million and $12.5 million, respectively, for the three and nine months ended September 30, 2005. Throughout 2004, Europe experienced sales growth when compared to 2003, partly due to the Billion Dollar promotion in the first and second quarters of 2004. Such sales growth was not expected to be sustainable in 2005. While some markets did sustain growth such as France, South Africa and Spain, two key markets, Germany and the Netherlands, experienced sales declines of 14.7% and 15.3%, and 19.9% and 13.3%, respectively, for the three and nine months ended September 30, 2005 when compared to the same periods in 2004.
      We have recently appointed a new country manager in Germany and the new management team is developing a turnaround plan for 2006 to re-engage the local distributor leadership and to rebuild the confidence among distributors to improve recruiting and retention. Similar to Germany, we have recently appointed a new country manager in the Netherlands and have taken steps to re-engage the local distributor leadership in the Netherlands. Several new initiatives are planned in the second half of 2005, including a new recruiting program, and we expect this will contribute to improved performance beginning in 2006.
      Net sales in Spain were up $1.4 million and $7.4 million, or 17.1% and 31.8%, respectively, for the three and nine months ended September 30, 2005, as compared to the same periods in 2004. The increase in sales is primarily due to unified distributor leadership, an increasing emphasis locally on health and nutrition and the continuing positive impact of certain promotions in 2005. Net sales in France were up $1.7 million and $5.7 million, or 28.7% and 30.9%, respectively, for the three and nine months ended September 30, 2005, as compared to the same periods in 2004, partly due to adoption of a new nutritional distributor training program and a special vacation promotion. In South Africa, net sales increased $2.5 million and $5.6 million, or 72.2%, and 59.9%, respectively, for the three and nine months ended September 30, 2005 when compared to the same periods in 2004, primarily due to a unified distributor leadership. Additionally, in South Africa, we celebrated our 10th anniversary of doing business in the country with a major sales event during the third quarter.
      We believe that 2005 net sales in Europe will finish flat to slightly positive year over year partly due to sales increases we expect to generate from the ongoing Worldwide Cup promotion and new product introductions.

21


Table of Contents

Asia/Pacific Rim
      Net sales in Asia/ Pacific Rim increased $11.2 million and $31.8 million, or 20.8%, and 21.3%, respectively, for the three and nine months ended September 30, 2005, as compared to the same periods in 2004. In local currency, net sales increased by 14.7% and 14.9%, respectively, for the three and nine months ended September 30, 2005, as compared to the same periods in 2004. The fluctuation of foreign currency rates had a positive impact on net sales of $3.5 million and $9.6 million, respectively, for the three and nine months ended September 30, 2005. The overall sales increase was attributable mainly to an increase in Taiwan and South Korea.
      Net sales in Taiwan increased $6.1 million and $16.8 million, or 34.1% and 32.8%, for the three and nine months ended September 30, 2005, as compared to the same periods in 2004, due primarily to effective local training and recognition initiatives, unified leadership, and promotion of the 10th year anniversary of doing business in Taiwan held in the third quarter. Net sales in South Korea increased $5.6 million and $9.9 million, or 67.0% and 38.4% for the three and nine months ended September 30, 2005, as compared to the same periods in 2004. Continued successful sales of Niteworkstm, unified leadership, coupled with other recruiting initiatives have now established an eight quarter trend of positive year-over-year sales growth. New distributors and supervisors in the third quarter increased by 45% and 55%, respectively, compared to the same period in 2004.
      Overall, we believe that unified distributor leadership, new product launches, continued local distributor training and recognition, and effective promotions will contribute to ongoing sales increases in the Asia/ Pacific Rim region in 2005.
Japan
      Net sales in Japan increased $1.7 million or 7.6%, for the three months ended September 30, 2005, as compared to the same period in 2004, and they decreased $2.7 million or 3.7% for the nine months ended September 30, 2005, as compared to the same period in 2004. In local currency, net sales increased by 8.2% and for the three months ended September 30, 2005, and decreased by 4.9% for the nine months ended September 30, 2005, as compared to the same periods in 2004. The fluctuation of foreign currency rates had a negative impact on net sales of $0.3 million for the three months ended September 30, 2005, and a positive impact on net sales of $0.8 million for the nine months ended September 30, 2005. The third quarter net sales increase represents the first quarterly net sales increase in six years. We believe that the numerous initiatives to stimulate sales in Japan are beginning to make a positive impact, including a new sales center in a more attractive area in Tokyo, local management implementing initiatives to re-engage and motivate the local distributor leadership to improve recruiting and retention of distributors, expanding our product line to address local country demographic needs and the creation of increased brand awareness through sporting event sponsorships. In the third quarter NiteworksTM was introduced in Japan, and a special vacation promotion was launched. We believe the above initiatives in combination with the implementation of new brand and volume incentive promotional programs, should continue to improve sales trends for the balance of 2005.

22


Table of Contents

Sales by Product Category
                                                                                         
    Three Months Ended September 30,
     
    2004   2005
         
        Handling &           Handling &       % Change
    Retail   Distributor   Product   Freight   Net   Retail   Distributor   Product   Freight   Net   In Net
    Sales   Allowance   Sales   Income   Sales   Sales   Allowance   Sales   Income   Sales   Sales
                                             
    (Dollars in millions)
Weight Management
  $ 231.5     $ (114.0 )   $ 117.5     $ 19.9     $ 137.4     $ 299.0     $ (147.2 )   $ 151.8     $ 25.1     $ 176.9       28.7 %
Inner Nutrition
    233.3       (114.9 )     118.4       20.1       138.5       282.4       (139.0 )     143.4       23.7       167.1       20.6 %
Outer Nutrition®
    47.7       (23.5 )     24.2       4.1       28.3       62.8       (31.0 )     31.8       5.2       37.0       30.7 %
Literature, Promotional and
Other
    12.0       2.6       14.6       1.0       15.6       15.4       3.3       18.7       1.3       20.0       28.2 %
                                                                   
Total
  $ 524.5     $ (249.8 )   $ 274.7     $ 45.1     $ 319.8     $ 659.6     $ (313.9 )   $ 345.7     $ 55.3     $ 401.0       25.4 %
                                                                   
                                                                                         
    Nine Months Ended September 30,
     
    2004   2005
         
        Handling &           Handling &       % Change
    Retail   Distributor   Product   Freight   Net   Retail   Distributor   Product   Freight   Net   In Net
    Sales   Allowance   Sales   Income   Sales   Sales   Allowance   Sales   Income   Sales   Sales
                                             
    (Dollars in millions)
Weight Management
  $ 705.7     $ (347.1 )   $ 358.6     $ 60.9     $ 419.5     $ 848.2     $ (417.7 )   $ 430.5     $ 71.5     $ 502.0       19.7 %
Inner Nutrition
    699.6       (344.1 )     355.5       60.4       415.9       805.2       (396.5 )     408.7       67.9       476.6       14.6 %
Outer Nutrition®
    144.6       (71.1 )     73.5       12.5       86.0       208.1       (102.5 )     105.6       17.4       123.0       43.0 %
Literature, Promotional and Other
    34.1       9.6       43.7       2.9       46.6       43.1       9.4       52.5       3.6       56.1       20.4 %
                                                                   
Total
  $ 1,584.0     $ (752.7 )   $ 831.3     $ 136.7     $ 968.0     $ 1,904.6     $ (907.3 )   $ 997.3     $ 160.4     $ 1,157.7       19.6 %
                                                                   
      Our increased emphasis on the science of weight management and nutrition during the past two years has resulted in product introductions such as Niteworkstm and Garden 7 tm and the introduction of ShapeWorkstm, a personalized meal replacement program. Due to the launch of ShapeWorkstm in March 2004 in the United States and the on-going roll-out to other countries, the introduction of new Outer Nutrition® products like NouriFusiontm, and the increased use of the Total Plan by distributors in Brazil and worldwide, which uses Outer Nutrition products as its foundation, net sales of weight management products and Outer Nutrition® products increased at a higher rate than net sales of inner nutrition products. Sales of Outer Nutrition products increased 30.7% and 43.0%, respectively, for the three and nine months ended September 30, 2005, which are greater rates than those for any other categories. Literature, Promotional and Other, which is net of product buy-backs and returns in all product categories, increased primarily due to an increase in literature sales from selling starter kits to new distributors and from a decrease in returns and refunds. We expect growth rates within these categories will vary, from time to time, as we launch new products.
Gross Profit
      Gross profit was $321.5 million and $925.1 million for the three and nine months ended September 30, 2005, as compared to $250.8 million and $769.2 million for the same periods in 2004.
      As a percentage of net sales, gross profit for the three months ended September 30, 2005 increased from 78.4% to 80.2%, as compared to the same period in 2004. The increase in gross profit as a percentage of net sales for the three months ended September 30, 2005 reflected lower provisions for slow moving and obsolete inventory as well as changes in country and product sales mix.
      As a percentage of net sales, gross profit for the nine months ended September 30, 2005 increased from 79.5% to 79.9%, as compared to the same period in 2004. Generally, gross profit percentages do not vary significantly as a percentage of sales other than due to ongoing cost reduction initiatives and provisions for slow moving and obsolete inventory or due to product and/or country mix. Additionally, we believe that we

23


Table of Contents

have the ability to mitigate price increases by raising the prices of our products or shifting product sourcing to alternative manufacturers.
Royalty Overrides
      Royalty Overrides as a percentage of net sales were 34.6% and 35.5% for the three and nine months ended September 30, 2005, respectively, as compared to 35.0% and 35.4% for the same periods in 2004. The decrease for the three months ended September 30, 2005 was primarily due to a favorable pre-tax impact of $4.0 million relating to a change in the allowance for uncollectible royalty overrides receivables from distributors in the third quarter of 2005, partially offset by a favorable pre-tax impact of $2.4 million of aged royalty checks in the third quarter of 2004. Generally, royalty overrides as a percentage of net sales varies slightly from period to period due to changes in the mix of products and countries because varying Royalty Overrides are paid on certain products and in certain countries. Due to the structure of our global compensation plan coupled with the current country mix of our business, we do not expect to see significant fluctuations in Royalty Overrides as a percent of net sales.
Selling, General & Administrative Expenses
      Selling, General & Administrative expenses as a percentage of net sales were 30.3% and 30.2%, respectively, for the three and nine months ended September 30, 2005, as compared to 32.1% and 32.6% for the same periods in 2004. For the three and nine months ended September 30, 2005, Selling, General & Administrative expenses increased $18.8 million and $33.6 million, respectively, to $121.6 million and $349.4 million, respectively. The unfavorable impact of foreign currency fluctuations was $2.4 million and $7.5 million for the three and nine months ended September 30, 2005, respectively.
      The increase in Selling, General, & Administrative expenses for the three months ended September 30, 2005 included $8.2 million in higher salaries and benefits, due to normal merit increases, increased staffing, and higher incentive compensation; $9.4 million in additional advertising and promotion expenses related primarily to our Worldwide Cup promotion; $1.5 million relating to legal and professional fees primarily associated with strengthening our technology infrastructure. The increases were partially offset by $3.4 million lower amortization expense of intangibles and $1.4 million lower monitoring fees and other expenses due to the termination of the related agreement with Whitney and Golden Gate.
      The increase in Selling, General, & Administrative expenses for the nine months ended September 30, 2005 included $22.2 million in higher salaries and benefits, due to normal merit increases, increased staffing, and higher incentive compensation; $6.9 million relating to legal and litigation expenses and additional professional fees primarily associated with strengthening our technology infrastructure; $9.9 million in additional advertising and promotion expenses related primarily to our 2005 Worldwide Cup promotion. The increases were partially offset by $5.2 million lower amortization expense of intangibles; $4.9 million lower monitoring fees and other expenses due to the termination of the related agreement with Whitney and Golden Gate and a $0.1 million foreign exchange gain in 2005 versus a $2.1 million loss in 2004.
      We expect 2005 Selling, General & Administrative expenses to increase over 2004 levels, reflecting general salary merit increases, moderate staffing additions, further expansion in China and increased sales events activities, although as a percentage of net sales, these expenses should be slightly down from 2004 levels.
Net Interest Expense
      Net interest expense was $8.0 million and $37.6 million for the three and nine months ended September 30, 2005, respectively, as compared to $13.6 million and $55.2 million for the same periods in 2004. This includes $14.2 million and $15.4 million of recapitalization expenses for the three months ended March 31, 2005 and 2004, respectively. The recapitalization expenses were due to the redemption of 40% or $110 million principal amount of the 91/2% Notes completed in February 2005 and the redemption of the 151/2% senior notes completed in March 2004. During the second and third quarters of 2005 we prepaid

24


Table of Contents

$35.0 million and $44.7 million under our senior credit facility, respectively, resulting in approximately $0.7 million and $0.9 million additional interest expense from write-off of deferred financing fees.
Income Taxes
      Income taxes were $26.2 million and $64.0 million for the three and nine months ended September 30, 2005, respectively, as compared to $11.0 million and $32.7 million for the same periods in 2004. As a percentage of pre-tax income, the effective income tax rate was 49.1% and 50.3% for the three and nine months ended September 30, 2005, respectively, as compared to 48.9% and 58.6% for the same periods in 2004. The decrease in the effective tax rate for the nine months ended September 30, 2005 as compared to 2004 was caused primarily by the impact of less non-deductible interest including the aforementioned non-deductible recapitalization charges in each period. Offsetting these benefits was a $5.5 million non-cash tax charge associated with moving our China subsidiary within our global corporate structure in the second quarter of 2005 and an increase in taxes due to the impact on our worldwide transfer pricing and tax structure as a result of stronger than expected revenue growth during the past several quarters and management outlook that a mid-teens revenue growth rate will continue throughout 2006. Excluding the impact of the recapitalization expenses of $14.2 million and $15.4 million during the first quarter of 2005 and 2004, respectively, and the $5.5 million non-cash tax charge associated with China, the effective tax rate would have been approximately 41.4% and 37.3% for the nine months ended September 30, 2005 and 2004, respectively.
Foreign Currency Fluctuations
      Currency fluctuations had a favorable impact of $3.5 million and $10.6 million on net results for the three and nine months ended September 30, 2005, when compared to what current year net results would have been using last year’s foreign exchange rates. For the three months ended September 30, 2005, the regional effects were an unfavorable $0.2 million in Europe, a favorable $0.9 million in Asia/ Pacific Rim, a favorable $2.7 million in The Americas, and a favorable $0.1 million in Japan. For the nine months ended September 30, 2005, the regional effects were a favorable $2.2 million in Europe, a favorable $2.7 million in Asia/ Pacific Rim, a favorable $4.5 million in The Americas, and a favorable $1.1 million in Japan.
Net Income
      For the three months ended September 30, 2005, net income was $27.1 million, or 37 cents per diluted share compared to net income of $11.5 million, or 21 cents per diluted share for the same period in 2004. Net income as reported includes a favorable post-tax impact of $2.5 million relating to a change in the allowance for uncollectible royalty overrides receivables from distributors in the third quarter of 2005, partially offset by the $1.5 million favorable post-tax impact of aged royalties in the third quarter of 2004. The improvement in net income was the result of a 25.4% increase in net sales, the continued favorable impact from appreciation of foreign currencies, lower interest and income tax expense partially offset by higher operating expenses primarily from increased labor, benefits, incentive compensation and promotion expense. Overall, the appreciation of foreign currencies had a $3.5 million favorable impact on net income for the three months ended September 30, 2005.
      For the nine months ended September 30, 2005, net income was $63.2 million, or 87 cents per diluted share compared to a net income of $23.1 million, or 42 cents per diluted share reported for the same period in 2004. Net income as reported includes the effect of recapitalization transaction expenses of $14.2 million and $15.4 million in the first quarters of 2005 and 2004, respectively, and a non-cash tax charge of $5.5 million associated with moving our China subsidiary within the global corporate structure in the second quarter of 2005, and the favorable post-tax impact of $2.5 million relating to a change in the allowance for uncollectible royalty overrides receivables from distributors in the third quarter of 2005, partially offset by the $1.5 million post-tax favorable impact of aged royalties in the third quarter of 2004. The improvement in net income was the result of a 19.6% increase in net sales, the continued favorable impact from appreciation of foreign currencies, lower interest and income tax expense partially offset by higher operating expenses primarily from increased labor, benefits and incentive compensation. Overall, the appreciation of foreign currencies had a $10.6 million favorable impact on net results for the nine months ended September 30, 2005.

25


Table of Contents

Liquidity and Capital Resources
      We have historically met our working capital and capital expenditure requirements, including funding for expansion of operations, through net cash flows provided by operating activities. Our principal source of liquidity is our operating cash flows. Variations in sales of our products would directly affect the availability of funds. There are no material restrictions on the ability to transfer and remit funds among our international affiliated companies.
      For the nine months ended September 30, 2005, we generated $130.9 million from operating cash flows, as compared to $81.0 million in 2004. The improved operating cash flow was primarily due to the 19.6% increase in net sales, partially offset by higher receivables resulting from higher sales volume and higher operating expenses primarily from increased labor, benefit and incentive compensation.
      Capital expenditures, including capital leases, for the nine months ended September 30, 2005 were $22.3 million, as compared to $20.7 million in 2004. The majority of these expenditures represented investments in management information systems, internet tools for distributors, the relocation of our facility in Japan and the expansion of our facilities in China. We expect to incur total capital expenditures of up to $35.0 million in 2005 primarily related to investments in management information systems, internet tools for distributors, office facilities and our expansion in China.
      2005 and 2006 are investment years for us in China as we expand our business there. We currently anticipate to fund an operating loss of approximately $5.0 million and $10.0 million in 2005 and 2006, respectively, in addition to total capital expenditures and working capital of up to $15.0 million for the planned build-out of retail stores, our offices and the expansion of the capabilities of our manufacturing facility. As of September 30, 2005 we have invested approximately $2.0 million in capital expenditures.
      In December 2004, Herbalife completed an initial public offering in connection with which several recapitalization transactions were completed, including the tender for all of the outstanding 113/4% Notes, of which 99.9% accepted the tender offer, and a replacement of the existing term loan and revolving credit facility with a new $225.0 million senior credit facility. In addition, we redeemed $110 million principal amount excluding discounts or 40% of our outstanding 91/2% Notes in February of 2005 for the cash amount of $124.1 million, including a premium of $10.5 million and accrued interest of $3.6 million. Interest expense for the first six months of 2005 includes the redemption amount of $14.2 million which represents $10.5 million of premium and $3.7 million of write off of deferred financing cost and discount.
      The $225.0 million senior credit facility consists of a senior secured revolving credit facility with total availability of up to $25.0 million and a senior secured term loan facility in an aggregate principal amount of $200.0 million. The revolver is available until December 21, 2009. The revolver bears interest at LIBOR plus 2%. In April 2005 the senior credit facility was amended whereby the interest rate was reduced from LIBOR plus 21/4% to LIBOR plus 13/4%. In addition, the amount payable in connection with a partial or full refinancing of the loan within the first year of the amendment shall equal 101% of the principal amount. During the second quarter of 2005 we prepaid $35.0 million of our senior credit facility resulting in approximately $0.7 million additional interest expense from write-off of deferred financing fees.
      In August 2005, the senior credit facility was amended to permit the purchase, repurchase or redemption of up to $50.0 million aggregate principal amount of the 91/2% Notes due 2011. There were no repurchases during the third quarter. During the third quarter of 2005 we prepaid an additional $44.7 million of our senior credit facility resulting in approximately $0.9 million additional interest expense from write-off of deferred financing fees. With regard to the term loan we are obligated to pay $0.3 million every quarter until September 30, 2010 and the remaining principal amount on December 21, 2010. As of September 30, 2005, no amounts had been borrowed under the revolving credit facility.
      The senior credit facility and the 91/2% Notes include customary covenants that restrict, among other things, the ability to incur additional debt, pay dividends or make certain other restricted payments, incur liens, merge or sell all or substantially all of our assets, or enter into various transactions with affiliates. Additionally, the senior credit facility includes covenants relating to the maintenance of certain leverage, fixed

26


Table of Contents

charge coverage, and interest coverage ratios, and requirements to make early payments to the extent of excess cash flow, as defined therein.
      The following summarizes our contractual obligations including interest at September 30, 2005 and the effect such obligations are expected to have on our liquidity and cash flows in future periods:
                                                         
    Payments Due by Period
     
        2010 &
    Total   2005   2006   2007   2008   2009   Thereafter
                             
    (In millions)
Senior Secured Term Loan
  $ 152.3     $ 1.9     $ 7.7     $ 7.6     $ 7.6     $ 7.5     $ 120.0  
113/4% Notes
    0.2                                     0.2  
91/2% Notes
    259.0       7.8       15.7       15.7       15.7       15.7       188.4  
Capitalized leases
    5.2       0.5       3.1       1.6                    
Other debt
    2.7       0.3       1.5       0.9                    
Operating leases
    24.9       4.0       12.5       3.3       1.7       1.1       2.3  
                                           
Total
  $ 444.3     $ 14.5     $ 40.5     $ 29.1     $ 25.0     $ 24.3     $ 310.9  
                                           
      Whitney and Golden Gate (and/or their affiliates) were parties to a Share Purchase Agreement (the “Share Purchase Agreement”) pursuant to which they originally purchased our Preferred Shares. Under the terms of the Share Purchase Agreement, Whitney and Golden Gate could, subject to approval by our board of directors and 75% of our shareholders, require us to pay a dividend to all of our shareholders related to certain income that may be taxable to them resulting from their ownership of our shares. We completed our analysis with regard to this payment and based on this analysis, we made $1.4 million and $4.9 million dividend payments to our shareholders in the fourth quarter of 2004, related to certain income that may be taxable to them for the years ended December 31, 2003 and December 31, 2004, respectively.
      In December 2004, we entered into a termination agreement with the parties to the Share Purchase Agreement. Pursuant to the termination agreement, the Share Purchase Agreement and all obligations and liabilities of the parties under the Share Purchase Agreement were terminated. As consideration for the termination of the Share Purchase Agreement, we have entered into a Tax Indemnification Agreement with Whitney and Golden Gate (and/or their affiliates) pursuant to which we have agreed to indemnify each of those parties for the Federal income tax liability and any related losses they incur in respect of income of Herbalife that is (or would be) includible in the gross income of that party for any taxable period under Section 951(a) of the Internal Revenue Code of 1986, as amended (the “Code”). Under the terms of the Tax Indemnification Agreement, we assume, for this purpose, that each indemnified party is a “United States shareholder” as defined in Section 951(b) of the Code. We do not, however, have any obligation to provide an indemnity with respect to any taxes or related losses incurred that have been reimbursed under the Share Purchase Agreement. Our senior credit facility permits us to pay these tax indemnity payments, but restricts the aggregate amount that we can pay in any given year to no more than $15 million. We currently anticipate that any amounts that we are required to pay under this agreement in the future will be immaterial to our financial condition and operating results.
      In connection with the initial public offering we paid a special cash dividend to stockholders of record prior to the offering in the amount of $139.7 million.
      The declaration of future dividends is subject to the discretion of our board of directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by our credit agreement, cash requirements, future prospects and other factors deemed relevant by our board of directors. Our credit agreement permits payments of dividends as long as no default exists and the amount does not exceed $20.0 million per fiscal year provided that the amount of dividends may be increased by 25% of the consolidated net income for the prior fiscal year if the Leverage Ratio (as defined in our credit agreement) for the four fiscal quarters of such fiscal year is less than or equal to 2.00:1.00.

27


Table of Contents

      As of September 30, 2005, we had working capital of $9.4 million compared to negative $1.6 million at December 31, 2004. Cash and cash equivalents were $105.2 million at September 30, 2005, compared to $201.6 million at December 31, 2004.
      We expect that cash and funds provided from operations and available borrowings under our revolving credit facility will provide sufficient working capital to operate our business, to make expected capital expenditures and to meet foreseeable liquidity requirements, including debt service on the 91/2% Notes and the senior credit facility. There can be no assurance, however, that our business will service our debt, including our outstanding notes, or fund our other liquidity needs.
      The majority of our purchases from suppliers are generally made in U.S. dollars, while sales to Herbalife distributors generally are made in local currencies. Consequently, strengthening of the U.S. dollar versus a foreign currency can have a negative impact on operating margins and can generate transaction losses on intercompany transactions. For discussion of our foreign exchange contracts and other hedging arrangements, see the quantitative and qualitative disclosures about market risks described below.
Contingencies
      We are from time to time engaged in routine litigation. We regularly review all pending litigation matters in which we are involved and establish reserves deemed appropriate by management for these litigation matters when a probable loss estimate can be made.
      Herbalife International and certain of its distributors have been named as defendants in a purported class action lawsuit filed July 16, 2003 in the Circuit Court of Ohio County in the State of West Virginia (Mey v. Herbalife International, Inc., et al). The complaint alleges that certain telemarketing practices of certain Herbalife International distributors violate the Telephone Consumer Protection Act, or TCPA, and seeks to hold Herbalife International vicariously liable for the practices of its distributors. More specifically, the plaintiffs’ complaint alleges that several of Herbalife International’s distributors used pre-recorded telephone messages and autodialers to contact prospective customers in violation of the TCPA’s prohibition of such practices. Herbalife International’s distributors are independent contractors and, if any such distributors in fact violated the TCPA, they also violated Herbalife’s policies, which require its distributors to comply with all applicable federal, state and local laws. We believe that we have meritorious defenses to the suit.
      Herbalife International and certain of its independent distributors have been named as defendants in a purported class action lawsuit filed February 17, 2005 in the Superior Court of California, County of San Francisco, and served on Herbalife International on March 14, 2005 (Minton v. Herbalife International, et al). The case has been transferred to the Los Angeles County Superior Court. The plaintiff is challenging the marketing practices of certain Herbalife International independent distributors and Herbalife International under various state laws prohibiting “endless chain schemes,” insufficient disclosure in assisted marketing plans, unfair and deceptive business practices, and fraud and deceit. The plaintiff alleges that the Freedom Group system operated by certain independent distributors of Herbalife International products places too much emphasis on recruiting and encourages excessively large purchases of product and promotional materials by distributors. The plaintiff also alleges that Freedom Group pressured distributors to disseminate misleading promotional materials. The plaintiff seeks to hold Herbalife International vicariously liable for the actions of its independent distributors and is seeking damages and injunctive relief. The Company believes that we have meritorious defenses to the suit.
      In February 2005 Herbalife voluntarily elected to temporarily withdraw its Sesame & Herb tablet product from the Israeli market. This product, which has been on the market since 1989, is sold only in Israel. Herbalife’s voluntary decision to temporarily withdraw this product accompanied the initiation of a review by the Israeli Ministry of Health (the “Israel MOH”) of a small number of anecdotal case reports of individuals having liver dysfunction who had also consumed Herbalife products. Herbalife scientists and medical doctors are closely cooperating with the Israel MOH to facilitate this ongoing review. In May 2005, the Israel MOH issued a press release stating that although their investigation was continuing, no causal link has been shown between the consumption of Herbalife products and liver function abnormalities. In addition, the Israel MOH requested that individuals consuming or intending to consume Herbalife products obtain liver function tests

28


Table of Contents

before and one month after beginning their use, and that persons with liver function disorders refrain from consuming dietary supplements. Independent analysis of Herbalife’s Israeli products has confirmed that Herbalife products do not contain any substances indicated by the Israel MOH as being of concern in relation to this small number of reported cases of liver dysfunction. Herbalife believes that Herbalife products are not the cause of these few reported anecdotal cases of liver dysfunction.
      As a marketer of dietary and nutritional supplements and other products that are ingested by consumers or applied to their bodies, we have been and are currently subjected to various product liability claims. The effects of these claims to date have not been material to us, and the reasonably possible range of exposure on currently existing claims is not material to us. We believe that we have meritorious defenses to the allegations contained in the lawsuits. We currently maintain product liability insurance with a self insured retention of $10 million.
      Certain of our subsidiaries have been subject to tax audits by governmental authorities in their respective countries. In certain of these tax audits, governmental authorities are proposing that significant amounts of additional taxes and related interest and penalties are due. We and our tax advisors believe that there are substantial defenses to their allegations that additional taxes are owed, and we are vigorously contesting the additional proposed taxes and related charges.
      These matters may take several years to resolve, and we cannot be sure of their ultimate resolution. However, it is the opinion of management that adverse outcomes, if any, will not likely result in a material effect on our financial condition and operating results. This opinion is based on our belief that any losses we suffer in excess of amounts reserved would not be material and that we have meritorious defenses. Although we have reserved an amount that we believe represents the likely outcome of the resolution of these disputes, if we are incorrect in our assessment, we may have to record additional expenses.
Critical Accounting Policies
      Our Consolidated Financial Statements are prepared in conformity with accounting principles generally accepted in the United States of America, which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the year. Actual results could differ from those estimates. We consider the following policies to be most critical in understanding the judgments that are involved in preparing the financial statements and the uncertainties that could impact our results of operations, financial condition and cash flows.
      We are a network marketing company that sells a wide range of weight management products, nutritional supplements and personal care products within one industry segment as defined under SFAS 131, “Disclosures about Segments of an Enterprise and Related Information.” Our products are manufactured by third party providers and then sold to independent distributors who sell Herbalife products to retail consumers or other distributors.
      We sell products in 60 countries throughout the world and are organized and managed by geographic region. In the first quarter of 2003, we elected to aggregate our operating segments into one reporting segment, as management believes that our operating segments have similar operating characteristics and similar long term operating performance. In making this determination, management believes that the operating segments are similar with regard to the nature of the products sold, the product acquisition process, the types of customers products are sold to, the methods used to distribute the products, and the nature of the regulatory environment.
      Revenue is recognized when products are shipped and title passes to the independent distributor or importer. Amounts billed for freight and handling costs are included in net sales. We generally receive the net sales price in cash or through credit card payments at the point of sale. Related royalty overrides and allowances for product returns are recorded when the merchandise is shipped.
      Allowances for product returns primarily in connection with our buyback program are provided at the time the product is shipped. This accrual is based upon historic return rates for each country, which vary from

29


Table of Contents

zero to approximately 5.0% of Retail Sales, and the relevant return pattern, which reflects anticipated returns to be received over a period of up to 12 months following the original sale. Historically, product returns and buybacks have not been significant. Product returns and buybacks as a percentage of Retail Sales were approximately 0.97%, and 1.23%, and 0.99%, and 1.0%, for the three and nine months ended September 30, 2004 and 2005, respectively. No material changes in estimates have been recognized for the nine months ended September 30, 2004 and 2005.
      Royalty overrides receivables and related allowances for estimated uncollectible royalty overrides receivables are calculated and recorded as contra-liabilities to the royalty overrides liabilities on the balance sheet. During the third quarter of 2005, we changed the way we estimate the allowances based on new information that allows us to analyze royalty overrides receivables and offsetting royalty overrides payable balances. Consequently, the change in estimate to the allowance for uncollectible royalty overrides receivable was reduced by $4.0 million during the quarter ended September 30, 2005.
      We record reserves against our inventory to provide for estimated obsolete or unsalable inventory based on assumptions about future demand for our products and market conditions. If future demand and market conditions are less favorable than management’s assumptions, additional reserves could be required. Likewise, favorable future demand and market conditions could positively impact future operating results if previously reserved for inventory is sold. We reserved for obsolete and slow moving inventory totaling $6.2 million and $8.1 million as of December 31, 2004 and September 30, 2005, respectively.
      In accordance with Statement of Financial Accounting Standards (“SFAS”) 144, long-lived assets, such as property, plant, and equipment, and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of would be separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and are no longer depreciated. The assets and liabilities of a disposed group classified as held for sale would be presented separately in the appropriate asset and liability sections of the balance sheet. Goodwill and other intangibles not subject to amortization are tested annually for impairment, and are tested for impairment more frequently if events and circumstances indicate that the asset might be impaired. An impairment loss is recognized to the extent that the carrying amount exceeds the asset’s fair value. This determination is made at the reporting unit level and consists of two steps. First, the Company determines the fair value of a reporting unit and compares it to its carrying amount.
      Second, if the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill and other intangibles over the implied fair value. The implied fair value is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation, in accordance with SFAS No. 141, Business Combinations. The residual fair value after this allocation is the implied fair value of the reporting unit goodwill and other intangibles. As of September 30, 2005, we had goodwill of approximately $144.6 million, and marketing franchise of $310.0 million. Goodwill was reduced in the third quarter by approximately $16.0 million to reflect a reduction in the valuation allowance established at the time of the Acquisition against pre-Acquisition tax benefits.
      Contingencies are accounted for in accordance with SFAS 5, “Accounting for Contingencies.” SFAS 5 requires that we record an estimated loss from a loss contingency when information available prior to issuance of our financial statements indicates that it is probable that an asset has been impaired or a liability has been incurred at the date of the financial statements and the amount of the loss can be reasonably estimated. Accounting for contingencies such as legal and income tax matters requires us to use judgment. Many of these legal and tax contingencies can take years to be resolved. Generally, as the time period increases over which the uncertainties are resolved, the likelihood of changes to the estimate of the ultimate outcome increases.
      Deferred income tax assets have been established for net operating loss carryforwards of certain foreign subsidiaries and have been reduced by a valuation allowance to reflect them at amounts estimated to be

30


Table of Contents

ultimately recognized. The net operating loss carryforwards expire in varying amounts over a future period of time. Realization of the income tax carryforwards is dependent on generating sufficient taxable income prior to expiration of the carryforwards. Although realization is not assured, we believe it is more likely than not that the net carrying value of the income tax carryforwards will be realized. The amount of the income tax carryforwards that is considered realizable, however, could change if estimates of future taxable income during the carryforward period are adjusted.
New Accounting Pronouncements
      In December 2004, the Financial Accounting Standards Board (“FASB”) enacted Statement of Financial Accounting Standards 123 — revised 2004 (“SFAS 123R”), “Share-Based Payment” which replaces Statement of Financial Accounting Standards No. 123 (“SFAS 123”), “Accounting for Stock-Based Compensation” and supersedes Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees.” SFAS 123R requires the measurement of all employee share-based payments to employees, including grants of employee stock options, using a fair-value-based method and the recording of such expense in our consolidated statements of income. The accounting provisions of SFAS 123R are effective for reporting periods beginning after December 15, 2005.
      We are required to adopt SFAS 123R in the first quarter of fiscal 2006. The pro forma disclosures previously permitted under SFAS 123 no longer will be an alternative to financial statement recognition. See Note 8 in our Notes to Consolidated Financial Statements for the pro forma net income and net income per share amounts, for the three and nine months ended September 30, 2004 and 2005, respectively, as if we had used a fair-value-based method similar to the methods required under SFAS 123R to measure compensation expense for employee stock incentive awards. Although we have not yet determined whether the adoption of SFAS 123R will result in amounts that are similar to the current pro forma disclosures under SFAS 123, we are evaluating the requirements under SFAS 123R and on a preliminary basis we expect the adoption will not have a material impact on our consolidated statements of income, relative to currently existing options.
      In December 2004, the FASB issued FASB Staff Position No. FAS 109-2 (“FAS 109-2”), “Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creations Act of 2004” (“AJCA”). The AJCA introduces a limited time 85% dividends received deduction on the repatriation of certain foreign earnings to a U.S. taxpayer (“repatriation provision”), provided certain criteria are met. FAS 109-2 provides accounting and disclosure guidance for the repatriation provision. This provision will not provide a material benefit to the Company.
      In December 2004, the FASB issued SFAS No. 151, “Inventory Costs, an amendment of ARB No. 43, Chapter 4,” which requires that abnormal amounts of idle facility expense, freight, handling costs and wasted material (spoilage) be recognized as current-period charges. In addition, the statement requires that allocation of fixed production overheads to the costs of conversion be based on the normal capacity of the production facilities. SFAS No. 151 is effective for fiscal years beginning after June 15, 2005. We will adopt this statement as required, and we do not believe the adoption will have a material effect on our results of operations, financial condition or liquidity.
      In May 2005, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 154, “Accounting Changes and Error Corrections.” SFAS No. 154 requires restatement of prior periods’ financial statements for changes in accounting principle, unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. Also, SFAS No. 154 requires that retrospective application of a change in accounting principle be limited to the direct effects of the change. SFAS No. 154 is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005.

31


Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk
      We are exposed to market risks, which arise during the normal course of business from changes in interest rates and foreign currency exchange rates. On a selected basis, we use derivative financial instruments to manage or hedge these risks. All hedging transactions are authorized and executed pursuant to written guidelines and procedures.
      We have adopted SFAS 133, “Accounting for Derivative Instruments and Hedging Activities.” SFAS 133, as amended and interpreted, established accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. All derivatives, whether designated in hedging relationships or not, are required to be recorded on the balance sheet at fair value. If the derivative is designated as a fair-value hedge, the changes in the fair value of the derivative and the underlying hedged item are recognized concurrently in earnings. If the derivative is designated as a cash-flow hedge, changes in the fair value of the derivative are recorded in other comprehensive income (“OCI”) and are recognized in the statements of income when the hedged item affects earnings. SFAS 133 defined new requirements for designation and documentation of hedging relationships as well as ongoing effectiveness assessments in order to use hedge accounting. For a derivative that does not qualify as a hedge, changes in fair value are recognized concurrently in earnings.
      A discussion of our primary market risk exposures and derivatives is presented below.
Foreign Exchange Risk
      We enter into foreign exchange derivatives in the ordinary course of business primarily to reduce exposure to currency fluctuations attributable to intercompany transactions and translation of local currency revenue. Some of these foreign exchange contracts are designated as cash flow hedges for forecasted transactions.
      We purchase average rate put options, which give us the right, but not the obligation, to sell foreign currency at a specified exchange rate (“strike rate”). These contracts provide protection in the event that the foreign currency weakens beyond the option strike rate.
      The following table provides information about the details of our option contracts:
                                 
        Average        
Foreign Currency   Coverage   Strike Price   Fair Value   Maturity Date
                 
    (In millions)       (In millions)    
Purchase Puts (Company may sell yen/buy USD)
                               
Japanese yen   $ 4.5       99.7-100.9     $ 0.5       Q4 2005  
Purchase Puts (Company may sell euro/buy USD)
                               
Euro   $ 10.2       1.31-1.36     $ 1.0       Q4 2005  
Purchase Puts (Company may sell BRL/buy USD)
                               
Brazilian Real   $ 5.0       2.29-2.39     $       Q4 2005  
Purchase Puts (Company may sell MXP/buy USD)
                               
Mexican Peso   $ 0.5       10.87     $       Q4 2005  
      Foreign exchange forward contracts are used to protect against changes in the functional currency equivalent value of inter-company or third party nonfunctional currency payables or receivables. The fair value of forward contracts is based on third-party bank quotes.
      The following table provides information about the details of our forward contracts used to hedge intercompany loans and other foreign exchange exposures. These forward contracts are renewed and adjusted

32


Table of Contents

monthly to coincide with the rollover and any changes in the amount of intercompany loans and foreign exchange exposures.
                                         
    Contract   Forward       Contract    
Foreign Currency   Date   Position   Maturity Date   Rate   Fair Value
                     
        (In millions)           (In millions)
                     
At September 30, 2005
                                       
Buy SEK sell USD
    9/29/2005     $ 2.4       10/31/2005       7.80     $ 2.4  
Buy EUR sell USD
    9/29/2005     $ 0.9       10/31/2005       1.20     $ 0.9  
Buy GBP sell USD
    9/29/2005     $ 3.2       10/31/2005       1.76     $ 3.2  
Buy YEN sell USD
    9/29/2005     $ 19.2       10/31/2005       112.51     $ 19.1  
Buy KRW sell USD
    9/29/2005     $ 1.5       10/31/2005       1,033.80     $ 1.5  
Buy JPY sell USD
    9/29/2005     $ 4.0       10/31/2005       113.07     $ 4.0  
Buy INR sell USD
    9/29/2005     $ 5.3       10/31/2005       44.05     $ 5.3  
Buy CNY sell USD
    9/29/2005     $ 15.0       10/31/2005       8.07     $ 15.0  
Buy CAD sell Euro
    9/29/2005     $ 1.5       10/31/2005       1.42     $ 1.6  
Buy NZD sell Euro
    9/29/2005     $ 0.4       10/31/2005       1.76     $ 0.4  
Buy AUD sell Euro
    9/29/2005     $ 0.8       10/31/2005       1.59     $ 0.8  
Buy TWD sell Euro
    9/29/2005     $ 3.3       10/31/2005       39.94     $ 3.3  
Buy NOK sell Euro
    9/29/2005     $ 0.5       10/31/2005       7.82     $ 0.5  
Buy USD sell Euro
    9/29/2005     $ 0.7       10/31/2005       1.20     $ 0.7  
Buy Euro sell USD
    9/28/2005     $ 13.9       10/31/2005       1.20     $ 14.0  
Buy HUF sell Euro
    9/29/2005     $ 0.2       10/31/2005       249.03     $ 0.2  
Buy EUR sell USD
    9/29/2005     $ 6.4       10/31/2005       1.20     $ 6.4  
Buy Euro sell SEK
    9/29/2005     $ 0.6       10/31/2005       9.38     $ 0.6  
      All our foreign subsidiaries, excluding those operating in hyper-inflationary environments, designate their local currencies as their functional currency. At September 30, 2005, the total amount of our foreign subsidiary cash was $82.1 million, of which $9.4 million was invested in U.S. dollars.
Interest Rate Risk
      We use interest rate swaps to hedge the interest rate exposure on the variable interest rate associated with our senior credit facility. They provide protection in the event the LIBOR rates fluctuate. Interest rate swaps are designated as cash flow hedges. The table below describes the interest rate swap that was outstanding:
                                 
    Notional           Maturity
Interest Rate   Amount   Average Rate   Fair Value   Date
                 
    (In millions)       (In millions)    
At September 30, 2005
                               
Interest rate swap
  $ 125.0       4.16%       Current $0.44       1/28/2008  
                      Non-Current  $0.17          

33


Table of Contents

      The table below presents principal cash flows and interest rates by maturity dates and the fair values of our borrowings as of September 30, 2005. Fair values for fixed rate borrowings have been determined based on recent market trade values. The fair values for variable rate borrowings approximate their carrying value. Variable interest rates disclosed represent the rates on the borrowings at September 30, 2005. Interest rate risk related to our capital leases is not significant.
                                                                   
    Expected Maturity Date
     
    2005   2006   2007   2008   2009   Thereafter   Total   Fair Value
                                 
Long-term Debt
                                                               
 
Fixed Rate (in millions)
  $     $     $     $     $     $ 0.1     $ 0.1     $ 0.1  
 
Average Interest Rate
                                                    11.75 %        
 
Variable Rate (in millions)
  $ 0.3     $ 1.2     $ 1.2     $ 1.2     $ 1.2     $ 113.9     $ 119.0     $ 119.0  
 
Average Interest Rate
                                                    5.41 %        
 
Fixed Rate (in millions)
  $     $     $     $     $     $ 165.0     $ 165.0     $ 179.0  
 
Average Interest Rate
                                                    9.5 %        
      Under the $200.0 million term loan, the Company is obligated to enter into (for a minimum of three years after December 21, 2004) an interest rate hedge for up to 25% of the aggregate principal amount of the term loan. On February 24, 2005 the Company entered into an interest rate swap, as discussed above, to fulfill this obligation.
Item 4. Controls And Procedures
Evaluation of Disclosure Controls and Procedures
      Our management, including our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the fiscal quarter covered by this report (the “Evaluation Date”). Based on such evaluation, such officers have concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective in alerting them on a timely basis to material information relating to the Company (including our consolidated subsidiaries) required to be included in our periodic filings under the Exchange Act.
Changes in Internal Control Over Financial Reporting
      There were no changes in our internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
FORWARD LOOKING STATEMENTS
      This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words “may,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” and other similar words.
      Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed in this document. Important factors that could cause our actual results, performance and achievements, or industry

34


Table of Contents

results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:
  •  our relationship with, and our ability to influence the actions of, our distributors;
 
  •  adverse publicity associated with our products or network marketing organization;
 
  •  uncertainties relating to interpretation and enforcement of recently enacted legislation in China governing direct selling;
 
  •  adverse changes in the Chinese economy, Chinese legal system or Chinese governmental policies;
 
  •  risk of improper action by Chinese employees or international distributors in violation of Chinese law;
 
  •  changing consumer preferences and demands;
 
  •  the competitive nature of our business;
 
  •  regulatory matters governing our products, including potential governmental or regulatory actions concerning the safety or efficacy of our products, and network marketing program;
 
  •  risks associated with operating internationally, including foreign exchange risks;
 
  •  our dependence on increased penetration of existing markets;
 
  •  contractual limitations on our ability to expand our business;
 
  •  our reliance on our information technology infrastructure and outside manufacturers;
 
  •  the sufficiency of trademarks and other intellectual property rights;
 
  •  product concentration;
 
  •  our reliance on our management team;
 
  •  product liability claims;
 
  •  uncertainties relating to the application of transfer pricing and similar tax regulations; and
 
  •  taxation relating to our distributors.
      Additional factors that could cause actual results to differ materially from our forward-looking statements are set forth in this quarterly report on Form 10-Q,, including under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and in our Financial Statements and the related notes. We do not intend, and undertake no obligation, to update any forward-looking statement.
      Before deciding whether to invest in our common shares, you should carefully consider and all information contained in this quarterly report on Form 10-Q. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements.
      Forward-looking statements in this quarterly report on Form 10-Q speak only as of the date hereof, and forward looking statements in documents attached are incorporated by reference speak only as of the date of those documents. The Company does not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

35


Table of Contents

PART II.     OTHER INFORMATION
Item 1.     Legal Proceedings
      See discussion under Note 5 to the Notes to the Consolidated Financial Statements included in Item 1 of this report.
Item 2.     Unregistered Sales of Equity Securities and Use of Proceeds
      None.
Item 3.     Defaults Upon Senior Securities
      None.
Item 4.     Submission of Matters to a Vote of Security Holders
      None.
Item 5.     Other Information
      (a) None.
      (b) None.
Item 6. Exhibits
      Exhibit Index:
                 
Exhibit        
Number   Description   Reference
         
  2 .1   Agreement and Plan of Merger, dated April 10, 2002, by and among Herbalife International, Inc., WH Holdings (Cayman Islands) Ltd. and WH Acquisition Corp.      (a)  
  3 .1   Form of Amended and Restated Memorandum and Articles of Association of Herbalife Ltd.      (d)  
  4 .1   Indenture, dated as of June 27, 2002 between WH Acquisition Corp., WH Intermediate Holdings Ltd., WH Luxembourg Holdings SàRL, WH Luxembourg Intermediate Holdings SàRL, WH Luxembourg CM SàRL and The Bank of New York as Trustee governing 113/4% Senior Subordinated Notes due 2010     (a)  
  4 .2   Indenture, dated as of March 8, 2004 between WH Holdings (Cayman Islands) Ltd., WH Capital Corporation and The Bank of New York as trustee governing 91/2% Notes due 2011     (a)  
  4 .3   Form of Share Certificate     (d)  
  9 .1   Shareholders’ Agreement dated as of July 31, 2002, by and among WH Holdings (Cayman Islands) Ltd., Whitney V, L.P., Whitney Strategic Partners V, L.P., WH Investments Ltd., CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG Investment Fund-AI, L.P., CCG AV, LLC-Series C, CCG AV, LLC-Series E, and certain other persons     (a)  
  9 .2   Voting Agreement, dated as of December 31, 2004 by and among Whitney V, L.P., Whitney Strategic Partners V, L.P., Whitney Private Debt Fund, L.P. and Green River Offshore Fund, Ltd., on the one hand, and CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC,, CCG Investment Fund-AI, LP, CCG AV, LLC-Series C, CCG AV, LLC-Series E and CCG CI, LLC on the other hand     (f)  

36


Table of Contents

                 
Exhibit        
Number   Description   Reference
         
  10 .1   Form of Indemnity Agreement between Herbalife International Inc. and certain officers and directors of Herbalife International Inc.      (a)  
  10 .2   Office lease agreement between Herbalife International of America Inc. and State Teacher’s Retirement System, dated July 11, 1995     (a)  
  10 .3   Herbalife International of America, Inc.’s Senior Executive Deferred Compensation Plan, effective January 1, 1996, as amended     (a)  
  10 .4   Herbalife International of America, Inc.’s Management Deferred Compensation Plan, effective January 1, 1996, as amended     (a)  
  10 .5   Master Trust Agreement between Herbalife International of America, Inc. and Imperial Trust Company, Inc., effective January 1, 1996     (a)  
  10 .6   Herbalife International Inc. 401K Profit Sharing Plan and Trust, as amended     (a)  
  10 .7   Trust Agreement for Herbalife 2001 Executive Retention Plan, effective March 15, 2001     (a)  
  10 .8   Herbalife 2001 Executive Retention Plan, effective March 15, 2001     (a)  
  10 .9   Separation Agreement and General Release, dated as of May 17, 2002, between Robert Sandler and Herbalife International, Inc. and Herbalife International of America, Inc. and Clarification     (a)  
  10 .10   Agreement for Retention of Legal Services, dated as of May 20, 2002, by and among Herbalife International, Inc., Herbalife International of America, Inc. and Robert A. Sandler     (a)  
  10 .11   Purchase Agreement, dated as of June 21, 2002, by and among WH Acquisition Corp., Herbalife International, Inc., WH Intermediate Holdings Ltd., WH Luxembourg Holdings SàRL, WH Luxembourg Intermediate Holdings SàRL, WH Luxembourg CM SàRL and UBS Warburg LLC     (a)  
  10 .12   Registration Rights Agreement, dated as of June 27, 2002, by and among WH Acquisition Corp., WH Intermediate Holdings Ltd., WH Luxembourg Holdings SàRL, WH Luxembourg Intermediate Holdings SàRL, WH Luxembourg CM SàRL and UBS Warburg LLC     (a)  
  10 .13   Notice to Distributors regarding Amendment to Agreements of Distributorship, dated as of July 18, 2002 between Herbalife International, Inc. and each Herbalife Distributor     (a)  
  10 .14   Indemnity Agreement dated as of July 31, 2002, by and among WH Holdings (Cayman Islands) Ltd., WH Acquisition Corp., Whitney & Co., LLC, Whitney V, L.P., Whitney Strategic Partners V, L.P., GGC Administration, L.L.C., Golden Gate Private Equity, Inc., CCG Investments (BVI), L.P., CCG Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV, LLC-Series C, CCG AV, LLC-Series C, CCG AV, LLC-Series E, CCG Associates-QP, LLC and WH Investments Ltd.      (a)  
  10 .15   Independent Director’s Stock Option Plan of WH Holdings (Cayman Islands) Ltd.     (a)  
  10 .16   Employment Agreement, dated as of March 10, 2003 between Brian Kane and Herbalife International, Inc. and Herbalife International of America, Inc.     (a)  
  10 .17   Employment Agreement dated as of March 10, 2003 between Carol Hannah and Herbalife International, Inc. and Herbalife International of America, Inc.     (a)  
  10 .18   Non-Statutory Stock Option Agreement, dated as of March 10, 2003 between WH Holdings (Cayman Islands) Ltd. and Brian Kane     (a)  
  10 .19   Non-Statutory Stock Option Agreement, dated as of March 10, 2003 between WH Holdings (Cayman Islands) Ltd. and Carol Hannah     (a)  
  10 .20   WH Holdings (Cayman Islands) Ltd. Stock Incentive Plan, as restated, dated as of November 5, 2003     (a)  
  10 .21   Side Letter Agreement dated as of March 10, 2003 by and among WH Holdings (Cayman Islands) Ltd., Brian Kane and Carol Hannah and the Shareholders listed therein     (a)  
  10 .22   Employment Agreement dated as of April 3, 2003 between Michael O. Johnson and Herbalife International, Inc. and Herbalife International of America, Inc.      (a)  

37


Table of Contents

                 
Exhibit        
Number   Description   Reference
         
  10 .23   Non-Statutory Stock Option Agreement, dated as of April 3, 2003 between WH Holdings (Cayman Islands) Ltd. and Michael O. Johnson     (a)  
  10 .24   Side Letter Agreement dated as of April 3, 2003 by and among WH Holdings (Cayman Islands) Ltd., Michael O. Johnson and the Shareholders listed therein     (a)  
  10 .25   Employment Agreement dated as of July 14, 2003 between Matt Wisk and Herbalife International of America, Inc.      (a)  
  10 .26   Employment Agreement dated as of July 31, 2003 between Gregory L. Probert and Herbalife International of America, Inc.      (a)  
  10 .27   Employment Agreement dated October 6, 2003 between Brett R. Chapman and Herbalife International of America, Inc.      (a)  
  10 .28   Form of Non-Statutory Stock Option Agreement (Non-Executive Agreement)     (a)  
  10 .29   Form of Non-Statutory Stock Option Agreement (Executive Agreement)     (a)  
  10 .30   Registration Rights Agreement, dated as of March 8, 2004, by and among WH Holdings (Cayman Islands) Ltd., WH Capital Corporation and UBS Securities, LLC     (a)  
  10 .31   Indemnity Agreement, dated as of February 9, 2004, among WH Capital Corporation and Gregory Probert     (a)  
  10 .32   Indemnity Agreement, dated as of February 9, 2004, among WH Capital Corporation and Brett R. Chapman     (a)  
  10 .33   Stock Subscription Agreement of WH Capital Corporation, dated as of February 9, 2004, between WH Capital Corporation and WH Holdings (Cayman Islands) Ltd.      (a)  
  10 .34   First Amendment to Amended and Restated WH Holdings (Cayman Islands) Ltd. Stock Incentive Plan, dated November 5, 2003     (a)  
  10 .35   Separation Agreement and General Release dated May 1, 2004, among Herbalife International, Inc., Herbalife International of America, Inc. and Carol Hannah     (a)  
  10 .36   Consulting Agreement dated May 1, 2004 among Herbalife International of America, Inc. and Carol Hannah     (a)  
  10 .37   Employment Agreement dated June 1, 2004 among Herbalife International of America, Inc. and Richard Goudis     (a)  
  10 .38   Purchase Agreement, dated March 3, 2004, by and among WH Holdings (Cayman Islands) Ltd., WH Capital Corporation and UBS Securities LLC     (a)  
  10 .39   Registration Rights Agreement, dated as of July 31, 2002, by and among WH Holdings (Cayman Islands) Ltd., Whitney V, L.P., Whitney Strategic Partners V, L.P., WH Investments Ltd., CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG Investment Fund-AI, L.P., CCG AV, LLC-Series C and CCG AV, LLC-Series E.     (b)  
  10 .40   Share Purchase Agreement, dated as of July 31, 2002, by and among WH Holdings (Cayman Islands) Ltd., Whitney Strategic Partners V, L.P., WH Investments Ltd., Whitney V, L.P., CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV, LLC-Series C and CCG AV, LLC-Series E.     (b)  
  10 .41   Form of Indemnification Agreement between Herbalife Ltd. and the directors and certain officers of Herbalife Ltd.      (c)  
  10 .42   Herbalife Ltd. 2004 Stock Incentive Plan, effective December 1, 2004     (c)  
  10 .43   Termination Agreement, dated as of December 1, 2004, between Herbalife Ltd., Herbalife International, Inc. and Whitney & Co., LLC.     (d)  
  10 .44   Termination Agreement, dated as of December 1, 2004, between Herbalife Ltd., Herbalife International Inc. and GGC Administration, L.L.C.     (d)  

38


Table of Contents

                 
Exhibit        
Number   Description   Reference
         
  10 .45   Termination Agreement, dated as of December 13, 2004, by and among Herbalife Ltd., Whitney V, L.P., Whitney Strategic Partners V, L.P., CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV, LLC-Series C, CCG AV, LLC-Series E and CCG CI, LLC.     (d)  
  10 .46   Indemnification Agreement, dated as of December 13, 2004, by and among Herbalife Ltd., Herbalife International, Inc., Whitney V, L.P., Whitney Strategic Partners V, L.P., CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV, LLC-Series C, CCG AV, LLC-Series E, CCG CI, LLC and GGC Administration, LLC.     (d)  
  10 .47   Amendment No. 1 to Herbalife Ltd. 2004 Stock Incentive Plan     (e)  
  10 .48   Form of Stock Bonus Award Agreement     (e)  
  10 .49   Contract for Services of a Consultant between Herbalife International Luxembourg S.á.R.L. and Brian Kane dated as of October 18, 2004     (f)  
  10 .50   Compromise Agreement between Herbalife International Luxembourg S.á.R.L. and Brian Kane dated as of October 18, 2004     (f)  
  10 .51   Credit Agreement, dated as of December 21, 2004, by and among Herbalife International Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L., HLF Luxembourg Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg Intermediate Holdings S.á.R.L. and the Subsidiary Guarantors party hereto, and certain lenders and agents named therein.     (g)  
  10 .52   Security Agreement, dated as of December 21, 2004, by and among Herbalife International, Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L., HLF Luxembourg Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg Intermediate Holdings S.á.R.L., and the Subsidiary Guarantors party thereto in favor of Morgan Stanley & Co. Incorporated, as Collateral Agent.     (g)  
  10 .53   First Amendment to Credit Agreement, dated as of April 12, 2005, by and among Herbalife International Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L., HLF Luxembourg Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg Intermediate Holdings S.á.R.L. and the Subsidiary Guarantors party thereto, and certain lenders and agents named therein.     (g)  
  10 .54   Employment Agreement Effective as of January 1, 2005 between Herbalife Ltd. and Henry Burdick     (h)  
  10 .55   Form of 2004 Herbalife Ltd. 2004 Stock Incentive Plan Stock Option Agreement     (i)  
  10 .56   Form of 2004 Herbalife Ltd. 2004 Stock Incentive Plan Non-Employee Director Stock Option Agreement     (i)  
  10 .57   Second Amendment to Credit Agreement, dated as of August 19, 2005, by and among Herbalife International, Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L., HLF Luxembourg Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg Intermediate Holdings S.á.R.L. and the Subsidiary Guarantors party thereto, and certain lenders and agents named therein.     (k)  
  10 .58   Service Agreement by and between Herbalife Europe Limited and Wynne Roberts ESQ, dated as of September 6, 2005.     (l)  
  10 .59   Amendment to employment agreement between Michael O. Johnson and Herbalife International, Inc. and Herbalife International of America, Inc., dated May 15, 2005.       *
  31 .1   Certification of Chief Executive Officer       *
  31 .2   Certification of Chief Financial Officer       *
  32 .1   Certificate Pursuant to Section 906 of the Sarbanes-Oxley Act       *

39


Table of Contents

                 
Exhibit        
Number   Description   Reference
         
  99 .1   Disposition Agreement dated as of December 13, 2004 is by and among Whitney V, L.P., a Delaware limited partnership, Whitney Strategic Partners V, L.P., a Delaware limited partnership, Whitney Private Debt Fund, L.P., a Delaware limited partnership and Green River Offshore Fund, Ltd., a Cayman Islands company on the one hand, and CCG Investments (BVI), L.P., a British Virgin Islands limited partnership, CCG Associates-QP, LLC, a Delaware limited liability company, CCG Associates-AI, LLC, a Delaware limited liability company, CCG Investment Fund-AI, LP, a Delaware limited partnership, CCG AV, LLC-Series C, a Delaware limited liability company, CCG AV, LLC-Series E, a Delaware limited liability company and CCG CI, LLC a Delaware limited liability company on the other hand.     (d)  
 
  * Filed herewith.
(a) Previously filed on October 1, 2004 as an Exhibit to the Company’s registration statement on Form S-1 (File No. 333-119485) and is incorporated herein by reference.
 
(b) Previously filed on November 9, 2004 as an Exhibit to Amendment No. 2 to the Company’s registration statement on Form S-1 (File No. 333-119485) and is incorporated herein by reference.
 
(c) Previously filed on December 2, 2004 as an Exhibit to Amendment No. 4 to the Company’s registration statement on Form S-1 (File No. 333-119485) and is incorporated herein by reference.
 
(d) Previously filed on December 14, 2004 as an Exhibit to Amendment No. 5 to the Company’s registration statement on Form S-1 (File No. 333-119485) and is incorporated herein by reference.
 
(e) Previously filed on February 17, 2005 as an Exhibit to the Company’s registration statement on Form S-8 (File No. 333-122871) and is incorporated herein by reference.
 
(f) Previously filed on March 14, 2005 as an Exhibit to the Company’s Annual Report on Form 10-K for the year ended December 31, 2004 and is incorporated herein by reference.
 
(g) Previously filed on May 9, 2005 as an Exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2005 and is incorporated herein by reference.
 
(h) Previously filed on May 13, 2005 as an Exhibit to the Company’s Current Report on Form 8-K and is incorporated herein by reference.
 
(i) Previously filed on June 14, 2005 as an Exhibit to the Company’s Current Report on Form 8-K and is incorporated herein by reference.
 
(k) Previously filed on August 23, 2005 as an Exhibit to the Company’s Current Report on Form 8-K and is incorporated herein by reference.
 
(l) Previously filed on September 23, 2005 as an Exhibit to the Company’s Current Report on Form 8-K and is incorporated herein by reference.

40


Table of Contents

SIGNATURES
      Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
  HERBALIFE LTD.
  (Registrant)
  By:  /s/ Richard Goudis
 
 
  Richard Goudis
  Chief Financial Officer
Date: November 7, 2005

41